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Abstract
Since its early beginnings, almost ve decades ago, MRI has revolutionised medical
imaging, sustaining an active eld of research into new applications, and improved
understanding of the underlying mechanisms. Its complexity and exibility, as a non-
invasive imaging modality is simultaneously, an asset and a challenge. Quantitative
imaging provides a particular challenge due to an increased sensitivity to experimental
variations. The development of accurate and robust methods for quantitative magnetic
resonance requires protocols to be carefully calibrated to produce consistent results.
This necessitates the use of test objects with known, stable, congurable characteristics.
This thesis is aimed at the development of these test objects, and their use within
quantitative imaging, spectroscopy, and the development of new techniques.
First, a set of magnetic resonance test objects were created, and their relaxation
properties assessed. T1 and T2 are calculated using spin, and multi-spin echo sequences
respectively. Several contrast and gelling agents were assessed, and the relaxivity
estimated in each case. The protocol dependence of T1 estimation methods is examined
using a phantom and in-vivo study. Saturation and inversion recovery estimations are
compared to variable ip angle methods, and the statistical distributions of T1 maps
quantied. A series of calibrated phantom studies are conducted, assessing the analysis
methods used for in-vivo magnetic resonance spectroscopy. The concentration of brain
metabolites is varied within liquid and gel phantoms, and the ratio of GABA to NAA
is calculated using a number of analysis tools, and in-house software.
Finally, a magnetic resonance spectroscopy Hamiltonian simulator is implemented
in Matlab. The simulator is utilised by collaborators in developing a quantum control
framework. Optimal control is used to generate chemically selective RF pulses, and
initial experimental implementations explored.
The quantitative methods were found to exhibit both acquisition and analysis
method dependencies. However, results were largely consistent within methodology,
highlighting the need for consistency across sites to ensure valid comparison. The the-
oretical development of novel RF pulses has been successful, but much work remains
to approach experimental implementation.
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1 Introduction
In 1942, Wolfgang Pauli made the suggestion that particles posses an intrinsic angular mo-
mentum, a property he called spin. This was followed by the work of Isaac Rabi, Edward
Purcell and Felix Bloch in the late 30s and 40s, uncovering nuclear magnetic resonance
(NMR) properties resulting from strong magnetic eld. It was not until 1970s that MRI
truly began to emerge. Two-dimensional imaging methods introduced by Paul Lauterbur [4]
were followed by the work of Sir Peter Manseld [5, 6]. By 1980, three dimensional human
imaging was possible, and the rst commercial MRI scanners began to enter the market. The
non-invasive nature of the modality, coupled with excellent soft tissue contrast, has seen MRI
continue to grow [7,8], despite competition from imaging modalities such as x-ray, computed
tomography (CT), or positron emission tomography (PET), and its relatively high cost.
With an estimated three million MRI scans a year in England alone [9], the demand for ex-
perienced radiologists to interpret the images has never been greater. The most commonly
used MRI techniques generate qualitative data, which can only be eectively interpreted
by trained medical practitioners. More quantitative methods could potentially reduce the
burden placed on these highly trained sta.
Magnetic resonance oers more than simply structural information. Diusion weighted
imaging provides contrast based on the diusion of molecules. Knowledge of the directions
of diusion elucidates microscopic information about cell barriers within the body. Perfusion
imaging allows mapping of the perfusion of uids through the body, most commonly used in
conjunction with a contrast agent to enhance the sensitivity of the technique. Relaxometry
is a technique which aims to estimate fundamental magnetic properties of a particular tissue,
known as relaxation rates. While conventional MRI makes use of these properties to generate
contrast, relaxometry aims to explicitly quantify them. Magnetic resonance spectroscopy
(MRS) provides information about the chemical composition of the tissue in the form of a
spectrum. The latter two techniques are the main focus of this thesis.
Quantitative MR relies on the detection of biomarkers; essentially any molecule, struc-
ture, or process which is characteristic of a potential medical condition. In the case of relax-
ometry this means detecting changes in the estimated relaxation rates. Nuclear relaxation
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rates are sensitive to the surrounding chemical environment, and have established ranges for
dierent tissue types. Mapping relaxation rates can oer enhanced contrast over conven-
tional imaging, and unlike conventional imaging, is independent of hardware conguration.
In the case of magnetic resonance spectroscopy, detection of biomarkers relies on accurate
quantication of the spectrum. MR spectra can provide information regarding the presence
of a particular chemical, and also its concentration relative to the others in the same region.
In principle MRS can provide metabolic maps, two, or three dimensional spatial distribu-
tions of chemical composition (demonstrating it is a very powerful tool). However, analysis
of MRS data is dicult. With multiple signals overlapping to varying degrees, decomposing
the full signal into its composite parts is a technical challenge.
In order to develop these imaging modalities as quantitative techniques, it is important to
select consistent scanning protocols. An MR scan protocol is dened by a set of instructions
for the scanner, known as pulse sequences. The \pulses" are separated by timings that can
be varied by the operator, producing distinct results. The sequences themselves can also
vary, spectroscopy and relaxometry have multiple means of data acquisition. While these
methods claim to be measuring the same parameters, there are fundamental dierences that
inevitably lead to discrepancy in the results. In conventional imaging, these dierences are
less important, the radiologists simply need to observe contrast in the image. For large scale
quantitative imaging to be feasible, the choice of protocol and timings must be optimised
and standardised.
In order to explore quantitative imaging, it is important to have a stable reference to
compare to, especially for the development of new techniques. While data from human
subjects is important, the complexity of the imaging environment, and potential for biolog-
ical variation make it unfavourable as a reference. Test objects must have stable imaging
properties, have a reproducible manufacture procedure, and ideally mimic the conditions of
tissue. In MRI, this role can be lled by calibrated solutions or gels. It is possible to adjust
the relaxometric properties of a solution through the introduction of contrast and gelling
agents, while an MR spectrum may be modulated by introducing the desired chemicals into
the solution.
This thesis is focused around development and validation of techniques within these
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quantitative modalities. In the rst chapter, an introduction to the fundamental theory of
magnetic resonance is presented, including the quantum mechanical basis of MR, and the
common techniques employed. The second chapter focuses on the creation, and relaxometric
calibration of test objects for MRI, intended for use in quality assurance (QA) of scan
data, and development of new techniques. The third chapter continues with relaxometry,
using a set of test objects and volunteer scans to evaluate the performance of relaxation
rate quantication methods. Chapters four and ve focus on techniques in spectroscopy.
Chapter four examines the robustness of metabolite quantication, and methods in the
analysis of MRS data. Chapter ve introduces quantum simulation and control, and how
these techniques can be used to develop improved metabolite detection in magnetic resonance
spectroscopy. The nal chapter collates the results of the previous sections, discussing results
in broader terms, and the outlook for future work.
3
2 Theoretical background
In this chapter, an introduction to the theoretical descriptions of magnetic resonance physics
is provided, with further application-specic details dealt with in the respective chapters.
The classical analogous description is presented rst, followed by the basic quantum me-
chanical principles. Finally, some specic techniques and terminology are introduced.
2.1 Basics of magnetic resonance
An arbitrary rotating body, as described by classical rotational mechanics, has an angular
momentum, L, due to a rotational velocity, v, at a distance r from the centre of rotation. If
the rotating body is also electrically charged, the rotational motion creates a current loop,
which in turn generates a magnetic eld. The magnetic moment, , of a body of mass, m,
is given by:
 =
ev
2r
r2: (2.1)
This can be rewritten in terms of angular momentum:
 =
 e
2m

L = L; (2.2)
where  is dened as the gyromagnetic ratio of the object, the ratio of =L. If this object is
then placed within some externally generated magnetic eld, B0, its magnetic moment can
be written:
d
dt
= B0: (2.3)
The amplitude of  is constant, so Eq. (2.3) describes the uctuation of  relative to B0,
or the precession of the magnetic moment. The precession of  can also be written in terms
of angular velocity, and takes the following form:
d
dt
=  !0: (2.4)
Combining Eq. (2.3), and Eq. (2.4) we nd:
!0 = B0; (2.5)
f0 =

2
B0: (2.6)
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This is known as the Larmor equation, it describes the relationship between eld strength
and precessional frequency, f0, known as the Larmor frequency. This relationship is a fun-
damental concept of magnetic resonance physics.
2.2 Quantum mechanical description
Classical mechanics is not adequate to fully describe the physics of magnetic resonance. To
fully understand this phenomenon, we introduce the concept of spin, an inherently quantum
mechanical concept. Unlike its classical equivalent, the magnitude of the angular momentum,
L, of a body in the quantum regime is limited to a restricted set of distinct values:
L = h
p
I(I + 1); (2.7)
where I is the angular quantum number, and h is Planck's reduced constant: h = h=2. Spin
can be considered a kind of internal angular momentum of the particle, an intrinsic property
like mass or charge. I can only take integer or half-integer values, for bosons and fermions
respectively. Most MR applications deal with hydrogen nuclei, i.e., spin 1=2 protons. With
the magnitude of L established, the direction must still be dened. This is achieved through
the use of a second discrete quantum number, m. Consider a particular component of the
angular momentum, for example in the z direction:
Lz = hm; (2.8)
where m can take any integer value between I and  I, resulting in 2I+1 potential values. In
the absence of a eld, the 2J+1 values of MJ are degenerate. However, applying a magnetic
eld breaks this degeneracy, a phenomenon known as the Zeeman eect, or Zeeman splitting.
Quantisation of angular momentum will inevitably lead to the quantisation of the magnetic
moment. From Eq. (2.2), and Eq. (2.8), we nd that the z-component of the magnetic
moment is given by:
z = hm: (2.9)
If we again introduce an external eld, B0, the classical description of magnetic energy yields
the following expression
E =  zB0 =  hmB0: (2.10)
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The appearance of the m quantum number here suggests that the magnetic energy of this
system is also quantised. For a spin 1=2 particle, such as a hydrogen atom, there are therefore
only two energy levels (m = +1=2, m =  1=2) which have a separation of E:
E = hB0: (2.11)
Transitions between these energy levels can be driven through absorption of a resonant
photon, the energy of which can be described by:
E = hf0: (2.12)
Equating Eq. (2.12), and Eq. (2.11) we arrive, once again, at the Larmor equation (Eq. (2.6)):
f0 =

2
B0: (2.13)
Hence both classical and quantum formulations are able to arrive at the Larmor equation.
The recreation of classical results is a common theme throughout quantum mechanics, and
often forms a good sanity check, as the classical description should describe a macroscopic
approximation of a quantum phenomena. However, only a quantum description can ade-
quately capture the full dynamics of an MR system.
2.3 Macroscopic magnetisation
So far, only individual spins have been considered in the quantum description. However, in
a real system we have many spin 1=2 particles, randomly distributed. A spin-1=2 nucleus
has two distinct spin states; m = +1=2 with  parallel with B0, known as the j"i spin state,
and m =  1=2 with  anti-parallel with B0, known as the j#i spin state. The dierence in
population between the high and low energy states is in fact the source of the MR signal.
The population ratio can be written using the Boltzmann equation:
n"
n#
= eE=kBT = ehf=kBT ; (2.14)
 1 + hf
kBT
; (2.15)
where n" and n# are the populations of the j"i and j#i states respectively, kB is the Boltzmann
constant, T is the temperature in Kelvin, and Eq. (2.15) is a result of a Taylor series. So, for
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Figure 2.1: The magnetisation is initially in the longitudinal direction at time t = 0. As
the resonant B1 eld is applied, the magnetisation is rotated into the transverse plane, in a
spiral motion, by time t = T.
a 3T scanner, at body temperature, we are attempting to measure a population dierence
of 0:02%. At thermal equilibrium, the net magnetisation will be parallel to B0 in the
longitudinal, z-direction, with magnitude M0:
M0 =
NX
k=1
k = n"z + n#z =
h
2
(n"   n#) : (2.16)
This small additional component to B0 would be very dicult to observe experimentally, so
any MR experiment involves the rotation of the bulk magnetisation away from the longitudi-
nal direction, towards the transverse plane. This can be achieved by applying an additional
time-dependent magnetic eld, referred to as B1. This second eld is oscillatory in nature,
and applied perpendicular to B0, in the transverse plane. B1 can be described according to
Bmax1 cos(!t), where B
max
1 is the amplitude of the eld, and ! frequency of oscillation of the
eld. When ! coincides with the Larmor frequency of the spin system, the net magnetisa-
tion, experiences a torque rotating it in a spiral motion towards the transverse plane. This
dynamic is demonstrated in Fig. 2.1. As ! is found to be in the radio-frequency range for
most MR applications, the B1 are termed RF-pulses. The angle of rotation of the RF-pulse
depends on duration and amplitude which is applied. If a pulse is applied for long enough,
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B1 can be rotated into the transverse plane, or even beyond, towards the  z direction. This
gives rise to 90 and 180 RF-pulses, the basic building blocks of many MR pulse sequences.
If we switch o B1 as the net magnetisation reaches the transverse plane, it will now only
experience the original eld, B0, and will precess as before. However, now the net mag-
netisation of the sample is perpendicular to the main eld, and we are able to measure the
electromagnetic force it induces using the resonant receive coils of the scanner. This is the
basis of all MR science, and the origin of the signal we observe.
2.4 Relaxation
Figure 2.2: Transverse and longitudinal relaxation curves for short (green), and long (red)
relaxation times.
Directly after application of a 90 RF pulse, the magnetisation, M , will begin precessing
in the transverse plane. In reality, this motion is a damped precession, and as soon as
the pulse has concluded, the magnitude of the transverse magnetisation, Mxy, will begin
to decay. This decay in the observed signal is known as relaxation, and is formed by two
distinct processes; longitudinal and transverse relaxation.
2.4.1 Longitudinal relaxation - T1
Longitudinal relaxation is a decay process which aects the magnetisation in the z direction.
If we consider an excited system with Mz(t = 0) = 0 ,i.e., M is precessing in the transverse
plane. Over time, this system will begin to lose energy to the surrounding environment
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through heat, and electron interactions, for instance. As this energy dissipates, the spins
will increasingly tend to lower energy states, and the system will return towards its ther-
mal equilibrium magnetisation, M0. This process is referred to as spin-lattice relaxation, as
energy is transferred from the spins to the lattice. This is a general process, not just appli-
cable to lattices, but the name is a throw-back to early NMR experiments. As M relaxes,
magnetisation in the z direction is recovered, and takes the following form:
Mz = M0
 
1  e t=T1 ; (2.17)
where, T1 is the exponential time constant describing the recovery, and is known as the
longitudinal relaxation time. T1 can vary greatly from system to system, depending on the
molecular structure surrounding the nucleus in question, as well as the strength of B0, and
temperature of the medium. The dierences in T1 (and T2) are of fundamental importance
MRI.
2.4.2 Transverse relaxation - T2
As the name suggests, transverse relaxation is a process that occurs perpendicular to the
main static eld. At its essence, it is a loss of magnetisation phase coherence of the spin
system, resulting in an attenuation of the magnitude of Mxy. The spins of an excited
system will initially have a phase coherence in some transverse direction, say y, resulting
in a precessing magnetisation Mxy. Each individual spin in this system is embedded within
a complex molecular environment which, due to interactions and shielding, will produce
a small perturbation to the main eld, B. As per Eq. (2.6), the eld perturbation also
perturbs precessional frequency of the spin:
f 0 =

2
jB0 +Bj (2.18)
If the spin system encounters a distribution of elds, B, it will in turn exhibit a distribution
of precessional frequencies. So, over time, the phase coherence of the magnetisation will
be disrupted, as the more quickly precessing spins begin to separate themselves from the
slowest. This picture is perhaps a little simplied, in reality the entire ensemble of spins will
not be aligned in the y direction, but rather they are thermally distributed about y with a
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net phase coherence transferred from their M0 conguration. The decoherence of the spins
is an entropic process resulting from thermodynamic interactions between the spins. As
such, it can also be referred to as spin-spin relaxation. After a system is excited, spin-spin
relaxation will exponentially damp Mxy in the following form:
Mxy(t) = M
0
xye
 t=T2 ; (2.19)
where here, T2 is the time constant that governs transverse relaxation. Similarly to longitu-
dinal relaxation, the time constant T2 will vary depending on the target substance. T2 times
for any material will be shorter than the corresponding T1. For example, T1 of grey matter is
on the order of 1400 ms, whilst T2 would be around 100 ms [10]. Experimental quantication,
and associated nuances of these time constants will be discussed in greater detail in Sections
3, and 4. However, T2 as predicted molecular mechanisms, is always found to be longer than
the relaxation time observed in practice. The full time, known as T 2 , is compounded by the
eects of eld inhomogeneity. Whether a result of some defect in the B0 magnet itself, or
eld distortions resulting from magnetic susceptibility eects, the magnetic eld will always
have some spatially varying component which increases the transverse relaxation rates.
2.5 Image formation
2.5.1 Localisation
Applying a 90 excitation pulse and measuring the decay of the induced transverse magneti-
zation will result in acquiring the signal from the entirety of the sample. This is ne for NMR
of homogeneous samples, however, to capture the structure of a more complex environment,
for example a person, we must introduce a means to localise the signal. The most common
approach to localisation utilises magnetic eld gradients. This can be achieved through the
introduction if a new eld, one that varies linearly with position in z i.e. B = B0 + zG. As
per Eq. (2.6), we therefore also introduce a z dependence of the precessional frequencies of
the following form:
f(z) =

2
(B0 + zGs) ; (2.20)
where Gs is the gradient of the eld. This is the basis for virtually all localised MR pulse
sequences. The position dependence of precessional frequencies allows several spatial encod-
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Figure 2.3: Varying the intensity of the eld gradient, or the bandwidth of the RF pulse
allow a slice of a particular thickness to be selected.
ing methods to be applied. Perhaps the simplest is a practice known as slice selection; a
method which involves the simultaneous application of an RF pulse and eld gradient to
selectively excite a two dimensional \slice" of spins. The bandwidth of the RF pulse can be
selected such that it only aects a particular range of precessional frequencies. The range of
frequencies, in turn, will correspond to a range of positions in our sample, or the extent of our
slice, as shown in g. 2.3. The slice thickness is dened by the strength of the applied gra-
dient, and the bandwidth of the corresponding pulse, where stronger gradients, and smaller
bandwidths create narrower slices. It is common practice, however, for the bandwidth to be
held constant, and only the slice-select gradient strength varied. So, we have successfully
localised the signal to a two-dimensional slice, however, we need to localise the signal in the
other two dimensions in order to acquire a single local volume, or voxel. This requires the
introduction of additional gradient localisation methods, frequency and phase encoding.
2.5.2 Frequency encode gradients
Another method of localising the MR signal is to apply a gradient during readout, known
as frequency encoding. If a linear eld gradient is applied, this time in the x direction, we
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introduce an x dependence to our precessional frequencies:
f(x) =

2
(B0 + xGf ) : (2.21)
If the signal is sampled while this eld is applied, we are able to relate the signal, as a
function of frequency, to the position in x from which it originated.
2.5.3 Phase encoding gradients
Suppose we apply a linear gradient in y, for time, t, at some point between excitation and
readout. While the gradient is on, we again introduce a positional dependent precessional
frequency:
f(y) =

2
(B0 + yGy) : (2.22)
When the gradient is then turned o, the entire system precesses at its original frequency,
f0. While the gradient was active, a position-dependent phase oset was introduced to the
system. The magnitude of the phase shift is given by:
(y) = G(y)t: (2.23)
Combining these localisation techniques for the gradient directions, allows us to localise the
signal in all three dimensions. The result is a signal containing both frequency and phase
information, localised to a single slice. This frequency and phase information can be related
to the spatial positions of the sample via the Fourier transform. However, in order to generate
the resolution to form a useful image, multiple acquisitions of this localisation scheme are
required. A single signal acquisition will populate one line of k-space, a constructed frequency
space, related to the image by Fourier transform. A second acquisition of the signal, with
the strength of the phase encoding gradient changed, will add another line to k-space, as
represented in Fig. 2.4. Repeated acquisition of dierent phase encoding gradients will
iteratively add resolution to the image. There are alternative methods of sampling k-space,
for example, spiral, or radial trajectories. These can be advantageous in situations where
fewer phase acquisitions are necessary, to reduce scan time for instance, but will not be
detailed here.
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Figure 2.4: Representation of k-space after three acquisitions of a phase encoding gradient.
The array of signals (Black dots) are 2D fourier transformed to form an image, the resolu-
tion of which will increase with more acquisitions.
2.5.4 Pulse sequences
Sequences of gradients and RF pulses can quickly become cumbersome to describe, so are
often represented as pulse sequence diagrams. The sequence diagrams usually consist of four
parallel axes, each representing a dierent component of the sequence. An example can be
seen in Fig. 2.5. The top line represents the RF-pulses applied, the number and spacing of
these pulses will dictate the type of echo we receive. The following three axes correspond to
the eld gradients in the three orthogonal directions. From top to bottom they are; Gz or
GSlice, Gy or Gphase, and Gx or GFreq. The fth, and nal line corresponds to the readout
timing of the sequence. There are two common timing parameters associated with sequence
diagrams, the repetition time, and the echo time, TR and TE respectively. TR parametrises
the length of time between repetitions of the sequence, and is dened as the time between
the rst excitation pulse in each scan. It is often on the order of seconds to accommodate
the recovery of magnetisation between scans. As such, the choice or TR is closely related
to the T1 of the imaged materials. TE parametrises the length of an individual sequence,
and is dened as the time between the rst excitation pulse, and readout. TE will always be
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shorter than TR, by denition, and due to its relation with echo formation, is closely tied to
the T2 of the sample.
We have seen that if a single excitation pulse is applied, the spins throughout the entire
sample will produce a oscillatory signal known as a free induction decay (FID). However, an
FID has no localisation scheme, so signal must be acquired a dierent way for volumetric
sequences. Two common pulse sequences are shown in Fig. 2.5; the spin echo and the
gradient echo. A gradient echo can be formed using a single excitation pulse, essentially
manipulating the FID to reoccur. The FID signal is rst dephased by a eld gradient, much
like in phase encoding, then later the opposite polarity gradient is applied. The gradients
are calibrated such that the spins regain the phase coherence that was lost during the rst
gradient, and a gradient echo is formed at time TE.
(a) Gradient echo pulse sequence diagram. (b) Spin echo pulse sequence diagram.
Figure 2.5: Spin echo, and gradient echo pulse sequence diagrams. Main gradients are
shown in grey, re-phase gradients in blue, and crushers in red. Re-phase gradients are cal-
ibrated to undo any phase eects resulting from non-phase encoding gradients. The oppo-
site polarity is applied , so the net phase eect is zero. Crusher, or spoiler gradients are
used to eliminate unwanted signals. Their intended purpose in (b) is to destroy phase co-
herence of transverse magnetisation resulting from imperfect 180 pulses.
The spin echo takes advantage of the symmetry of T 2 decay, refocussing the signal into
an echo after localisation. The 180 pulses at time TE=2 reverse the eects of decoherence
by ipping them. The slower precessing signals, that were lagging behind the others, now
14
nd themselves at the front, and vice versa. The result is a spin echo at time TE. The signal
prole produced by dierent sequences can quickly become very complex. It is advantageous
to model the evolution mathematically, using a set of coupled dierential equations, the
Bloch equations.
2.6 The Bloch equations
In 1946, Felix Bloch described the phenomenon of magnetic induction [11]; the origin of the
MR signal. He derived a set of equations that model the evolution of the magnetisation
during an MR experiment. Earlier, it was shown that the equilibrium magnetisation, M0,
can be described as the sum of all individual magnetic moments of the system (2.16). This
equation can actually be generalised for total magnetisation [12]:
dM(t)
dt
= M(t) B(t); (2.24)
where B(t) is the generalised eld that includes both the static eld component, B0, and
an additional arbitrary time-dependent vector. So, we can inuence the magnetisation by
introducing a second magnetic eld. This has already been discussed briey, in the form of
RF pulses. The magnetic component of an RF eld in the x direction can be described as a
linearly polarised magnetic eld, B1:
B1(t) = 2B
max
1 cos (!t) x^; (2.25)
where, Bmax1 is the amplitude of the eld, ! the transmission frequency, and x^ is a unit vector
in the x direction. This eld can then be decomposed into two counter-rotating circularly
polarised elds:
B1(t) = B
max
1 [cos (!t) x^+ sin (!t) y^] +B
max
1 [cos (!t) x^  sin (!t) y^] : (2.26)
These two components will have dierent interactions with the spin system. The component
co-rotating with the system's magnetisation is considered to have a far more signicant
eect. While the counter-rotating component does have a small eect [13], it is considered
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negligible in this discussion. In this case, we can write Bx1 as:
Bx1 (t) = B
max
1 [cos (!t) x^  sin (!t) y^] ; (2.27)
= Bx1 cos (!t) +B
y
1 sin (!t) : (2.28)
In the absence of relaxation, Eq. (2.24) can decomposed and written in terms of B0 and B1:
dMx(t)
dt
=  (My(t)B0  Mz(t)By1) ; (2.29)
dMy(t)
dt
=  (Mz(t)B
x
1  My(t)B0) ; (2.30)
dMz(t)
dt
=  (Mx(t)B
y
1  My(t)Bx1 ) : (2.31)
These equations describe the ideal, non-dissipative precession of the eld. To include the
relaxation mechanisms, we can model them in terms of T1 and T2 to yield the full Bloch
equations:
dMx(t)
dt
=  (My(t)B0  MZ(t)By1) 
Mx(t)
T2
; (2.32)
dMy(t)
dt
=  (Mz(t)B
x
1  My(t)B0) 
My(t)
T2
; (2.33)
dMz(t)
dt
=  (Mx(t)B
y
1  My(t)Bx1 ) 
Mz(t) M0
T1
: (2.34)
The discussion so far dealt with the dynamics of MR in the laboratory reference frame,
with a xed Cartesian coordinate system. However, with precessing magnetisation, rotating
elds, and dissipative processes, Cartesian coordinates are not the best choice of frame of
reference. A far less cumbersome way to describe these mechanisms is in a co-rotating frame;
a Cartesian frame rotating about the static eld, with frequency !. We can then dene the
components of the magnetisation in this new frame:
M 0x = Mx cos(!t) +My sin(!t); (2.35)
M 0y = My cos(!t) Mx sin(!t); (2.36)
M 0z = Mz: (2.37)
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In this new frame, the Bloch equations can be written:
dM 0x(t)
dt
=   (!0   !)M 0y(t)  By
0
1 M
0
z(t) 
M 0x(t)
T2
; (2.38)
dM 0y(t)
dt
= (!0   !)M 0x(t) + Bx
0
1 M
0
z(t) 
M 0y(t)
T2
; (2.39)
dM 0z(t)
dt
= 
h
By
0
1 M
0
x(t) Bx
0
1 M
0
t(t)
i
  M
0
z(t) M0
T1
: (2.40)
The Bloch equations have many applications, and are routinely used to model MR signal.
This approach is utilised in the subsequent two chapters in order to experimentally determine
the relaxation times, T1, and T2, a process known as relaxometry. In order to do this, the
Bloch equations must be solved for the sequence used. In the presence of a time-dependent
eld, the z magnetisation can be dened [10]:
Mz(t)
d
=
M0 +Mz(t)
T1
; (2.41)
where Mz is the z-component of the magnetisation as it approaches M0, the equilibrium
value. After application of an RF pulse of ip angle  at time t = 0, the solution is
Mz(t) = M0 +
 
Mz(0
 ) cos   M0

e t=T1 ; (2.42)
where Mz(0
 ) is the z-magnetisation just before the application of the pulse, dened by
proton density, hardware callibration, and other factors. If we repeatedly apply the pulse
with time period Tp then we can enforce the following condition:
Mz(Tp) = Mz(0
 ): (2.43)
The steady state solution for the transverse magnetisation is then:
Mxy = M0
1  e TR=T1
1  e TR=T1 cos  sin ; (2.44)
where Mxy is the transverse magnetisation. Eq. (2.44) is the MR signal equation. This
equation can be used as a basis for the derivation of all sequences used in the relaxometry
studies in subsequent chapters. For example, the transverse magnetisation resulting from a
spin echo sequence (Fig. 2.5), can be modelled by setting  to 90. Eq. (2.44) then simplies
to:
Mxy = M0
 
1  e TR=T1 e TE=T2 : (2.45)
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A substance with a xed T1, T2, and M0 can be modelled as a function of TR and TE across
multiple acquisitions, allowing the estimation of T1 and T2 based on the acquired signal
intensities. Conversely, if T1 and T2 are known, the parameters of the sequence may be
optimised to maximise signal intensity, or the contrast between two tissues, for example fat
and muscle.
2.7 Magnetic resonance spectroscopy
2.7.1 Chemical shift
Thus far, the discussion has been restricted to include only a single type of spin, a homoge-
neous sample of Hydrogen atoms, for instance. While this is a good approximation for clinical
application | or indeed water based phantoms | the varying electromagnetic properties
of molecules actually provides an interesting avenue of study. The precessional frequency of
a spin, given by Eq. (2.6), a product of the gyromagnetic ratio and the magnitude of the
magnetic eld applied to the spin. However, the electronic environment surrounding the spin
in question has an eect. Electrons placed in the external eld, B0, will begin to precess
according to their gyromagnetic ratio, much like the nuclei. This precession will occur in
the opposite sense to that of the nuclear spins, and will generate a magnetic moment that
opposes B0. This results in a reduction in the local magnetic eld observed by the nuclei,
a phenomenon known as electronic shielding. The Larmor equation for a nucleus can be
amended to account for this reduction:
f0 =
 
2

B0(1  ); (2.46)
where  is the shielding constant of the atom in question. We nd that identical Hydrogen
nuclei precess at dierent frequencies, depending on their electronic environment. This shift
is known as the chemical shift of the nuclei. The value of the chemical shift can be trivially
expressed in units of Hz, however, as we can see from Eq. (2.46), the shift is dependent on
the magnitude of the eld, B0. This is inconvenient, and would make comparing chemical
shifts across dierent scanners inconvenient. This can be overcome by expressing the shift
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relative to reference compound, f ref0 , in units of PPM:
 =
f0   f ref0
f ref0
 106; (2.47)
where  is the chemical shift in PPM, and f0 is the frequency of the sample. The choice of
reference compound is a little less straightforward. The obvious choice might be to refer-
ence everything relative to water, due to its natural abundance in-vivo. However, the water
signal is often suppressed in spectroscopy to improve the detection of other signals, and
the frequency of the water peak can shift [14] by  0:01 PPM=C due to temperature. This
has lead to several external references being used; tetramethylsilane (TMS), the most com-
monly accepted reference in spectroscopy. Others have been used in acqueous solutions; 3-
(trimethylsilyl) propionate (TSP), and more notably, 2,2-dimethyl-2-silapentate-5-sulfonate
(DSS), a temperature and pH stable compound ideal for the task [14]. In-vivo it is common
to use NAA as a calibration peak for chemical shift. Its 2 PPM peak is one of the largest
resonances in the brain, and is stable with respect to both pH [15] and temperature [16]. If
we perform a Fourier transform on the complex time prole of the decaying magnetisation,
we acquire a frequency distribution of the signal components. To summarise, N nuclei with
distinct electronic environments will produce N distinct peaks, with separation dependent
on Eq. (2.46), shifted relative to the reference frequency.
2.7.2 Spin-spin coupling
Nuclei also interact with one and other. This further changes the spectrum, producing
splitting of the spectral peaks that must be considered. There are two means by which
spins can interact with one and other. Dipolar coupling is an interaction resulting from
the magnetic eld produced by one nucleus aecting another. However, in mobile, isotropic
uids, no net eect is observed due to molecular tumbling within the substance. For all
applications in this thesis, dipolar interactions can be seen as negligible, and dominated
by the eects of J-couplings. J-coupling, or scalar coupling, is an interaction transmitted
through the bonds of a molecule, via the intermediate electrons, a process sustained even in
mobile, isotropic uids. Consider a single spin-1=2 nucleus. It will have two possible energy
levels E" and E#, corresponding to the two spin states, j"i and j#i, respectively. Therefore
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there is only one possible energy transition; the dierence between these levels, E, with a
corresponding transition frequency, fT , given by Bohr's frequency relation:
E = hfT ; (2.48)
where h is Planck's constant. The frequency of this transition denes the location of its peak
within the spectrum. To include the eects of J-coupling we must again look at the electrons
of the atom. Electrons, like the nuclei considered here, also have two possible spin states,
leading to a total of four for the combined system; j""i, j"#i, j#"i, and j##i. These states
are not equally likely due to the interaction between the nucleus and its electrons, a process
known as Fermi contact. In quantum mechanics, the electron cannot be thought of as ball
of charge, as in classical mechanics, but rather a probability distribution. The electrons of
our atom have a non-zero probability to be detected within the nucleus, giving rise to the so
called hyperne interaction. Fermi contact leads the electron spins to prefer an anti-parallel
alignment to the nuclear spins; j"#i, j#"i. This phenomenon is not entirely relevant for an
isolated nuclear spin, but now consider a second nucleus, B, chemically bonded to the rst,
A. Uncoupled they produce single spectral resonances at fA and fB, respectively. However,
when they are bonded, this changes. The electronic interactions within the chemical bond
are governed by the Pauli exclusion principle, enforcing that the electron spin states be anti-
aligned. This will in turn aect how energetically favourable the states are, creating four
dierent energy transitions Fig. 2.6. Four energy transitions implies four peaks. The two
resonances fA and fB are each split into a pair of smaller peaks, known as a doublet. The
locations of these peaks is dened by the coupling strength;
fA0 = fA + J; (2.49)
fB0 = fB + J; (2.50)
where J is the size of the splitting in units of Hz, and a measure of the coupling strength
between the two nuclei. J is a measure of the strength of the coupling, and can be aected
by the number of bonds between spins, and their orientation. Unlike chemical shifts, J is
independent of eld strength, however at higher eld strengths, the larger chemical shift
spacing may allow better resolution of the J-coupling peaks.
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(a) Combined nuclear spin states of a pair of
coupled spin-1=2 nuclei.
(b) A simulated spectrum of a single resonance,
with and without coupling.
Figure 2.6: Uncoupled, these nuclei have one potential energy transition, therefore one res-
onance per nuclei. In the coupled spin system we see the \splitting" of the energy levels
opening 4 possible transitions; E1, E2, E3, and E4. This means that each of the
resonances splits into a doublet of two peaks.
More generally, a given spin may be bonded to many other nuclei. If a spin is coupled
to n equivalent spins, its peak is split into an (n + 1)-fold multiplet. The nomenclature of
the split peak structure is as follows:
 Singlet - A single isolated peak
 Doublet - Two peaks of equal intensity
 Triplet - Three peaks with a 1:2:1 ratio of intensities
 Quadruplet - Four peaks with a 1:3:3:1 ratio of intensities
 Quintet - Five peaks with a 1:4:6:4:1 ratio of intensities
where the ratios of the peaks can be calculated via binomial theorem, or using Pascal's
triangle for reference. However, the discussion so far has assumed the separation of the
chemical shifts of the peaks is much larger than the coupling. If this is not the case, this
simple binomial model does not hold, and second order coupling eects come into play.
In order to discuss these relative chemical shift separations, it is conventional to use an
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alphabetic representation. So for example, two well separated spins can be denoted as an
AX spin system, and two spins that resonate close to one and other could be denoted an AB
spin system. Nuclei with the same chemical environment, said to be chemically equivalent,
can also be represented in this fashion using a sub index; an AX2 system consists of two
chemically equivalent spins well separated from a third spin. The spectrum produced by an
AX2 system will depend on the coupling structure between them, with unique couplings,
the A resonance will split into triplet, as per the binomial description. However, if the
two X spins couple with the A spin with the same magnitude, then the X spins are not
just chemically equivalent, they are magnetically equivalent, and the A resonance will only
split once. Magnetically equivalent nuclei cause no further splitting to the spectrum. The
relative height of coupled multiplet peaks can also vary with time due to a process know
as J-evolution. After excitation, the X resonance of an uncoupled AX system will precess
at its Larmor frequency, fX . If a coupling, JAX , is introduced, the observed resonance
will split into a doublet; two peaks with frequencies fX  JAX . Over time, the dierence
between the two resonance frequencies will open a time-dependent phase dierence between
the resonances, a feature observable by varying the echo time. This phenomenon becomes
increasingly complex for nuclei with more couplings, and is only predicted by full quantum
mechqanical simulation (Sec.6).
2.7.3 Common sequences
Free induction decay The free induction decay (FID) is the simplest possible spec-
troscopy sequence. The FID consists of a single 90 excitation pulse followed, instantaneously,
by read-out Fig.2.7. The most notable feature of the sequence is the lack of any localisation
mechanism. The FID will excite the entire bulk of the sample, producing a non-localised
spectrum. This may well be sucient for phantoms and other homogeneous samples, but
for the more complex structures found in-vivo, the resulting spectrum will likely not yield
any benecial data. The term FID is often used synonymously for the signal generated by
any spectroscopy sequence.
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Figure 2.7: FID pulse sequence diagram.
Stimulated echo acquisition mode Unlike the FID, STimulated Echo Acquisition Mode
(STEAM) is a single voxel spectroscopy method, utilising a single-shot localisation mech-
anism. The STEAM sequence consists of three slice selective 90 Fig. 2.8, localising the
spectroscopic signal to a single voxel. The STEAM sequence generates a stimulated echo
after a time period TE + TM after the initial excitation pulse, where TM is known as the
mixing time. TM is not included in the echo time as the magnetisation is eectively stored
in the longitudinal direction, and as such does not undergo T2 decay.
Figure 2.8: STEAM pulse sequence diagram. With main gradients (grey), re-phase gra-
dients (blue), crushers (red). Re-phase and crusher gradients may vary, but this arrange-
ment is typical.
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Point-resolved spectroscopy Point RESolved Spectroscopy (PRESS) is a single voxel
spectroscopy technique which has been widely used in 1.5, and 3T MRS. The sequence
consists of three slice selective pulses, a 90, followed by two 180 RF pulses, as shown in
Fig.2.9 . PRESS produces a spin echo at time TE after the initial excitation pulse, with
signal only being emitted by the spins at the intersection of the three slices.
PRESS and STEAM are commonly used techniques, each with their own pros and cons.
For example, STEAM is able to achieve a much shorter echo times than PRESS, even as
low as 1 ms [17]. This makes it a preferred technique when attempting to detect metabolites
with relatively short T2 values. STEAM also has fewer restrictions with respect SAR. Its
use of 90 pulses, rather than 180, means it deposits less RF-energy in the target medium.
However, a major benet to PRESS is the nature of its echo formation. PRESS produces
a spin echo, rather than stimulated echo, meaning it will have an SNR approximately twice
that of STEAM for a given TR and TE [18]. This is a huge advantage at 1.5 and 3T, making it
the sequence of choice for the majority of clinical applications, despite the various advantages
of STEAM. That being said, at higher eld strengths T2 values increase, so the shorter echo
times of STEAM become more benecial as we enter the ultra-high eld regime.
Figure 2.9: PRESS pulse sequence diagram. With main gradients (grey), re-phase gradi-
ents (blue), crushers (red). Crusher gradient conguration can vary, but this is a typical
arrangement.
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Water suppression Water protons are present at concentrations of approximately 10,000
times that of major brain metabolites, and are therefore the pre-eminent source of the 1H MR
signal. The sequences, as described above, would yield spectra dominated by a water peak,
with other metabolic signals ambiguous to the noise oor. In order to detect the peaks of the
metabolites, the water signal must be suppressed. The most commonly used way to suppress
the water signal is chemical shift selective (CHESS) imaging [19]. CHESS involves applying
a frequency selective RF pulse within the range of the water signal, with a specied centre
frequency and bandwidth. The pulse rotates the magnetisation of the spins, specically
in this range, towards the transverse plane, where a strong crusher gradient is applied,
destroying the phase coherence of the water signal. The frequency selectivity of a pulse is
inversely proportional to its length, so the water selective pulses tend to be longer than a
standard broadband excitation pulse, typically 10-30ms. CHESS is easily implemented into
most spectroscopy sequences, with several CHESS pulses applied before the rst excitation
pulse of the sequence. Other water suppresion schemes are used, including band selective
inversion with gradient dephasing (BASING) [20], variable power RF pulses with optimized
relaxation delays (VAPOR) [21], water suppression enhanced through T1 eects [22], and
water suppression using selective echo dephasing [23], a precursor to the spectral editing
technique, MEGA-PRESS, which is the subject of the following section.
Spectral editing In general, editing is the term given to any process which changes the
spectral prole resulting from a given experiment. Spectral editing has already been dis-
cussed in relation to the suppression of the water signal, but it can be applied in other ways,
too. The most commonly used editing sequence is MEGA-PRESS, a scheme rst proposed
by Mescher and et al. in 1998 [24]. This is a dierence editing technique which involves ac-
quiring two data sets | the \edit on" and \edit o", respectively | and subtracting them
to acquire the dierence spectrum. The edit on scheme uses a PRESS sequence, but adds a
pair of frequency selective editing pulses symmetrically placed around the second refocussing
pulse Fig. 2.10. The frequency of the pulses is chosen to take advantage of the J-evolution of
the target metabolites. The edit o sequence supplies an non-edited spectrum, but for the
purpose of symmetry applies the editing at distant frequency, so as not to aect the target
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resonances. Acquisitions are alternated between on and o modes to reduce the inuence of
hardware limitations, then subtraction is carried out at the end. Although MEGA-PRESS
is a relatively general technique, the purpose of the editing pulse is most clearly explained
with a specic example. MEGA-PRESS is the most commonly used technique to detect
GABA in-vivo [25] [26] [27], and for this purpose, the editing pulse is applied at 1.9 PPM.
The pulses will only aect spins which are resonant in this frequency region. In the brain
this pertains to the GABA resonances at 1.9 PPM, the NAA peak at 2.0 PPM, the Glx
resonances at approximately 2.1 PPM, and other less relevant signals, including the macro-
molecular peaks in the same region. All of these signals will be removed from the on spectra
as a result of the editing, while all other signals are unaected, and therefore removed during
subtraction. Thus far it may appear that the edit on sequence simply removes signal from a
specic frequency range, however this neglects the process of J-evolution. While it is indeed
only resonances within the edit pulse bandwidth that are aected, some of these spins will
be J-coupled to other resonances outside of the edited region, and as the system evolves,
these are aected in turn. For GABA, the pair of spins at 1.9 PPM are coupled to a second
pair at 3 PPM. Likewise, the Glx peaks at 2.1 PPM have couplings to peaks around 3.75
PPM.
Other notable spectroscopy Sequences Chemical shift imaging (CSI) is a technique
that acquires spectra from multiple voxels in a grid. This is achieved by including spatial
phase-encoding gradients within another single voxel spectroscopy sequence. This can, in
principle, generate metabolic maps allowing spatial the distribution of metabolites to be
investigated.
Localisation by Adiabatic SElective Refocussing (LASER) [28] replaces the standard RF
pulses with adiabatic ones. While these pulses are longer than their counterparts, they have
the advantage of being insensitive to B1 inhomogeneity. This is especially useful at ultra-high
eld strengths, where RF homogeneity becomes more dicult to achieve.
2D spectroscopy [29, 30] is a technique that acquires multiple spectra across some pa-
rameter variation, for example multiple echo times. The length of TE changes the observed
spectrum, with short TE favouring short T2 spectra, and vice versa.
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Figure 2.10: MEGA-PRESS pulse sequence diagram, with main gradients (grey), re-phase
gradients (blue), crushers (red). The long shallow editing pulses that ank the second 180
refocussing pulse, are intermittently turned o to acquire the on and o spectra. There is
more than one way to implement a MEGA-PRESS sequence; dierent vendors have their
own implementation. [25]
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3 Test objects for quantitative imaging
3.1 Introduction
Test objects with known properties, generally referred to as phantoms in MRI, are an essen-
tial prerequisite for quality assurance [31,32] and the development, testing and optimization
of new techniques [33{35]. Phantoms can be prepared to mimic in-vivo environments [36],
to develop new sequences [37], or enhance existing ones [38, 39] as well as protocol develop-
ment and QA [40{42]. Test objects can also be used to asses eld inhomogeneity [31], and
even be employed across several imaging modalities, for example, MR-CT [43] and MR-CT-
ultrasound [44].
The type of phantom will dier depending on the requirements of the study, but some
aspects are common for all applications. There are some generally desirable criteria for a
successful test object: it should have relaxation times comparable to those of human tissue,
be robust with respect to manufacturing process and degradation, non-hazardous, and ideally
made from inexpensive, readily available materials that anyone can handle [45].
Most MR phantoms fall in one of two categories: aqueous solutions and gel based phan-
toms. Solutions are typically easier to prepare but generally not "tissue-mimicking\ as their
native T1 and T2 times are approximately equal, unlike human tissue, where T2 is typi-
cally much shorter than T1. Gel phantoms are generally prepared using an aqueous solution
mixed with a particular gelling agent, the most common being agar and agarose [46{50].
Agarose is a linear polymer, commonly extracted from seaweed, while agar is a composite
of agarose and a mixture of other smaller molecules. Alternatives include polyvinyl alcohol
(PVA) [51,52], another water-soluble linear polymer, and carrageenan; extracted from a vari-
ety of red seaweeds [53,54]. The choice and concentration of gelling agent inherently changes
the molecular structure, and therefore MR properties, of the phantom. T1 and T2 can also be
aected by paramagnetic contrast agents [55], which can be used to further tune relaxation
rates to mimic that of a particular tissue of interest, for example, white matter [50]. The
concentration of a given contrast agent has a xed relationship with the relaxation rate, this
is known as its relaxivity, knowledge of which is key in developing phantoms with specic
relaxation properties
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In this thesis we will be mainly concerned with phantoms for relaxometry and spec-
troscopy. Relaxometry is the process of determining the relaxation times T1, T2 (and T

2 )
of some sample, while spectroscopy exploits dierences in chemical shifts and coupling
structures of molecules that manifest in a spectroscopic ngerprint, allowing identication
and quantication of chemical compounds present in a sample. To facilitate the develop-
ment of suitable phantoms for these applications, we investigate the relaxivity of common
gelling agents (agar, agarose and PVA) and contrast agents (manganese and gadolinium) by
characterising a large series of phantoms prepared in-house.
3.2 Materials and Methods
3.2.1 Phantom preparation
For the investigation of the MRI properties of various gelling agents a set of phantoms made
by Gizem Portakal at the Cancer Research Wales Laboratories in Velindre Cancer Centre
[42] were used. Three dierent gelling agents, agar (#A7002, Sigma-Aldrich, Dorset, UK),
agarose (#A0169, Sigma-Aldrich), and PVA (99+% hydrolysis degree, #363146, Sigma-
Aldrich) were tested. For all phantoms Diazolidinyl urea (DU) (#D5146, Sigma-Aldrich)
was added as a preserving agent at a concentration of 6 mg ml 1. The amount of gelling
agent was varied, but all were dissolved in 18:2 M
 cm distilled water to the desired level.
The solutions were then maintained at a temperature of between 80 C and 90 C for 30 to
45 min whilst continuously stirred. The heated solutions were stored in 100 ml high density
polyethylene pots for the solidication process, Fig.3.1 . The agar and agarose gels may be
left overnight at room temperature to allow solidication to occur, or cooled in a refrigerator
or water bath to accelerate this process. The PVA gels required a more complex process of
freeze-thaw cycling. The solutions are stored in a freezer at  20 C for 10 h, then removed,
and stored at 20 C for 14 h. Four freeze thaw cycles were used for these gels. The initial study
of gelling agents, contained a total of fteen phantoms. They consisted of six agar gels at
concentrations of 1.0%, 1.5%, 2.0%, 2.5%, 3.0%, and 3.5%, six agarose gels at concentrations
of 0.5%, 1.0%, 1.5%, 2.0%, 2.5%, and 3.0%, and three PVA phantoms at concentrations of
10%, 15%, and 20%. Here 2% refers to 2 g=100ml of gelling agent.
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Figure 3.1: Image of one of the Agar gel phantoms
To investigate the relaxation properties for various contrast agents at 3T, two sets of
phantoms were made by myself, at the Centre for NanoHealth, Swansea University. The
contrast agents chosen were Manganese chloride (MnCl2) and Gadolinium oxide (Gd2O3).
For MnCl2, a 0:1 g L
 1 concentrate solution was made by dissolving manganese (II) chloride
tetrahydrate (98%) in deionised water. The concentrate was then further diluted to create a
series of seven 100 ml solutions with manganese chloride concentrations of 0, 10, 20, 30, 40,
50, and 60 mg L 1, where 10 mg l 1 corresponds to a 0:0505 mmol concentration of MnCl2.
As gadolinium oxide is insoluble in water at neutral pH, 4 g L 1 citric acid solution was
prepared to dissolve the Gd2O3. 1 g of di-gadolinium trioxide (anhydrous) was added to
form a concentrated solution. The concentrate was then further diluted to create a series
of eight 100 ml solutions with with Gd2O3 concentrations of 1, 2, 5, 10, 20, 30, 40 and 50
mg=100mL, where 1 mg=100mL corresponds to a 0:1379 mmol concentration of Gd2O3. All
fteen solutions were converted to 1% agar gels using the same process as above, with 0:1 g
of diazolidinyl urea again added as a preserving agent.
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3.2.2 Scan protocols
(a) Spin echo sequence diagram used for satura-
tion T1 determination.
(b) Multiecho sequence diagram. The eect
of T2 on the measured signal is shown by the
green dashed line.
Figure 3.2: Sequence diagrams for T1 and T2 quantication, respectively. Main gradients
(grey), re-phase gradients (blue), and crusher gradients (red).
All scans were conducted at Swansea university's Clinical Imaging Facility using a Siemens
3T Magnetom Skyra. The scanner room is a temperature controlled environment, maintained
at 20 C  0:6 C. The phantoms were placed on the patient table, and the built-in spine
coils used for signal acquisition. Specically, the four channel spine coil element \SP2" was
used, as it was assessed to have the highest SNR of all of the arrays. This combination
provided the most reproducible set up in terms of phantom arrangement, and coil loading,
while minimising the eect of individual channel phase osets. Longitudinal relaxation was
quantied using a saturation recovery spin echo sequence, with a xed TE of 12 ms, while TR
was varied across the following range: 125, 250, 500, 1000, 2000, 3000, 4000, 6000, and 7000
ms. Transverse relaxation estimation can be optimised by using a multi-spin echo sequence.
The multiecho sequence allows several signal acquisitions from a single excitation pulse. The
magnetisation is repeatedly refocussed creating multiple spin echoes within a single repeti-
tion time. The multi spin echo sequence xed TR at 3000 ms while TE was varied across 32
unique values: at 15 ms intervals from 15 to 480ms. R2 protocols were repeated after a year
of storage at room temperature to assess long term stability. Both sequence diagrams can
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be found in Fig.3.2.
(a) ROI for single phantom (b) 8 gel arrangement and ROIs (c) 7 gel arrangement and ROIs
Figure 3.3: Scan arrangements and ROIs (red) for the three set ups used in this study. Ar-
rangement (c) was deemed the optimal, balancing time eciency and susceptibility eects,
and was used for all subsequent studies with multiple phantoms.
For the pure gel measurements, the gels were scanned individually, with the phantom
directly on the patient table, directly below the isocentre. The eld of view for these scans
was 100  100 mm, the matrix size 128  128, and the readout bandwidth 130 Hz=pixel.
For the contrast agent series, the process was optimised, with the seven/eight gels of the
series placed in a symmetric arrangement about isocentre. The eld of view was increased
to 256 256 mm to accommodate the arrangement, the matrix size and readout bandwidth
were maintained at 128  128 mm, and 130 Hz=pixel, respectively. A 10 mm coronal slice
was acquired, to provide a cross sectional prole of the phantom(s).
3.2.3 Analysis
For each series, a circular region of interest (ROI) was manually dened using one image,
such that approximately 10% of the phantoms extent was excluded (Fig. 3.3), to reduce
boundary eects. For the solution series, where each image contained multiple phantoms,
a ROI was delineated for each one. The signal was dened as the mean across the circular
ROI, and the standard deviation used as a measure of uncertainty. Quantication of the
relaxation was achieved by tting a set of custom t functions using a trust-region-reective
least-squares minimisation algorithm, using the Matlab curve tting toolbox. Relaxation
rates were estimated, to improve characterisation, with R1 = 1=T1, and R2 = 1=T2.
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The starting point for both R1 and R2 estimation is the MR signal equation, dened
in the previous chapter (Eq. (2.45)). For R1 quantication, TE was xed, so the e
 TE=T2
term is constant, and can be absorbed into a scale factor, S0, along with M0, and Eq. (2.45)
simplies to:
Mxy(TR) = S0
 
1  e TRR1 : (3.1)
A custom t function was dened in Matlab, with Mxy as the mean signal over the phantom
ROI, TR is read in from the protocol information, and S0 and R1 are parameters to be
estimated. A similar reasoning can be applied to the R2 determination. If we now x TR,
Eq. (2.45) can be simplied by absorbing
 
1  e TR=T1 into a t coecient, S0:
Mxy(TE) = S0e
 TER2 ; (3.2)
or:
ln(Mxy) =  S 00
TE
R2
: (3.3)
For R2 quantication, the mean signal, Mxy, was plotted on a logarithmic scale against TE,
according to Eq. (3.3). A linear t was applied, with the gradient of the t providing a
measure of R2. If R2 is high enough, the signal may completely decay over the course of a
Figure 3.4: Mean signal plot for TE series (blue) and its linear t (red), with the noise
oor estimated using a ROI outside the extent of the phantom (black).
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TE series. This results in the R2 trend becoming non-linear for higher echo times, as signal
becomes indistinguishable from the noise. To ensure the accuracy of R2 estimations, the
linear t must be restricted to avoid tting the noise oor, so high TE points are excluded
from the ts. While this process can be automated, the exclusion threshold, itself, is rela-
tively arbitrary. For this study it was deemed sucient to manually exclude points in each
experiment. Fig. 3.4 shows an example of this process. The quality of each t is assessed
using the coecient of determination, R2, where an R2 of 1 indicates a perfect t, and 95%
condence intervals (CI) are reported where possible. Relaxivity was estimated by corre-
lating the relaxation rates with the respective concentration of gelling/contrast agent, and
applying a linear t. Again, the trust-region-reective least-squares minimisation algorithm
was used, and the R2 and 95% CI calculated.
3.3 Results
3.3.1 Gelling agents
TR and TE ts were generally found to be of high quality, with R
2 not dropping below 96%
across all gels, and all bar 3 ts had R2 above 99%. Fig. 3.5 shows the individual plots
for the TR and TE series, as well as the resulting relaxivities for the pure agar gels. With
concentrations between 1% and 3.5%, R1 was found to range between 0:362 s
 1 with 95% CI
of (0.342, 0.383) and 0:469 s 1 with 95% of (0.456, 0.482), and R2 between 5:008 s 1 (5.098,
4.918), and 12:675 s 1 (13.059, 12.290). The R1 relaxivity of agar was found to be 0.0354
(0.0166, 0.0543) s 1 mmol, and the R2 2.522 (-0.0686, 5.113) s 1 mmol. For agarose, R1
was found to vary between 0.348 s 1 with CI (0.330, 0.367) for 0.5%, and 0.399 s 1 with
CI (0.375, 0.422) for 3.0% agarose. R2 varied between 4.911 s
 1 with CI (4.950, 4.872),
and 21.261s 1 with CI (24.158, 18.363) for the same interval. Agarose was found to have
an r1 of 0.0222 s
 1 mmol with CI (0.0159, 0.0286), and r2 of 6.583 s 1 mmol with CI (6.07,
7.096). Individual plots may be found in Fig. 3.6. Fig. 3.7 shows the results for PVA, which
exhibited an R1 of 0.690 s
 1 with CI of (0.686, 0.694) for 10%, and 1.069 s 1 with CI (1.058,
1.081) for 20%. Its R2 varied between 6.141 s
 1 with CI (6.18, 6.10) and 13.42 s 1 (13.83,
13.01), for 10% and 20% respectively. Full R1 and R2 results for agar, agarose, and PVA
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(a) Agar TR ts (b) Agar R1 relaxivity
(c) Agar TE ts (d) Agar R2 relaxivity
Figure 3.5: Agar TR and TE plots, with error bars representing standard deviation across
ROI, and resulting relaxivity plot, with error bars representing the R2 of the R1 and R2
ts, respectively.
may be found in Table. A.1, along with 95% CIs, and R2 values.
3.3.2 Contrast agents
For the Gd2O3 the R1 protocol was applied on three separate occasions, with R1 found to
vary between 0.763 s 1 with CI (0.723, 0.802) for the 0 mmol phantom, to 30.825 s 1 with CI
(29.194, 32.456) for the 0:11 mmol phantom. The R1 relaxivity of Gd2O3 for the three scan
sessions was found to be 197.1s 1 mmol (152.7, 241.4), 195.1s 1 mmol (149.6, 240.7), and
177.8s 1 mmol (138, 217.6), with all values agreeing within 95% condence intervals. Gd2O3
35
(a) Agarose TR ts (b) Agarose R1 relaxivity
(c) Agarose TE ts (d) Agarose R2 relaxivity
Figure 3.6: Agarose TR and TE plots, with error bars representing standard deviation
across ROI, and resulting relaxivity plot, with error bars representing the R2 of the indi-
vidual t
maintains a consistent R1, even after 16 months of shelf storage. Fig. 3.8 shows the TR
plots, and resulting relaxivity plots. The R1 protocol was also applied multiple times to the
MnCl2, Fig. 3.9 shows the TR and relaxivity plots. R1 was found to vary between 0.331 s
 1
with CI (0.304, 0.358), and 4.221 s 1 with CI (4.154, 4.288) , for the 0 mmol and 0:30 mmol
respectively. The relaxivities for the three sessions were 0.631 s 1 mmol (0.524, 0.737), 0.588
s 1 mmol (0.458, 0.719), and 0.596 s 1 mmol (0.464, 0.727). Again, the relaxivities are found
to be consistent within 95% CIs, and are stable over a period of 16 months. Tab. A.4 contains
the full R1 data for the MnCl2 series. For Gd2O3, the R2 protocol was applied only once, with
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(a) PVA TR ts (b) PVA R1 relaxivity
(c) PVA TE ts (d) PVA R2 relaxivity
Figure 3.7: PVA TR and TE plots, with error bars representing standard deviation across
ROI, and resulting relaxivity plot, with error bars representing the R2 of the individual t
R2 found to vary between 10.136 s
 1 with CI (10.245, 10.027) for the 0 mmol phantom, and
47.156 s 1 with CI (48.430, 45.881) for the 0:11 mmol phantom. The R2 relaxivity of Gd2O3
was found to be 0.6973 s 1 mmol with CI (0.5965, 0.798). Fig. 3.10 shows the TE t and R2
relaxivity, consult Table. A.5 for full details. The MnCl2 R2 protocol was applied on three
separate occasions, the quantied R2 values were found to vary between 7.061 s
 1 (7.139,
6.982), and 57.390 s 1 (100.832, 13.947), for the 0 mmol and 0:30 mmol respectively. The
corresponding relaxivities were found to be 102.6 s 1 mmol (87.23, 117.9), 143.4 s 1 mmol
(116, 170.9), and 152.3 s 1 mmol (114.3, 190.3). The July 2017 MnCl2 results display an
increase of around 50% for r2 relaxivity, compared to those of the previous year. This
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(a) Gd2O3 Sept 16 (b) Gd2O3 Jan 18
(c) Gd2O3 Jan 18 (d) Gd2O3 R1 relaxivity
Figure 3.8: TR plots and resulting relaxivity estimation for Gd2O3. The multiple TR plots
relate to multiple acquistion instances.
feature is not explained by the condence intervals, and is not reected in the r1 relaxivities.
Fig. 3.11 contains the TE ts, and resulting relaxivity, with full details of TE ts included in
Table. A.5.
3.4 Discussion
Table. 3.1 shows the complete relaxivity results for both the gels and contrast agents. Agar
is found to have the lowest R2 out of the gelling agents in both r1 and r2, however, excluding
the 3.5% agar gel increases the R2 of the r1 t from 0.87 to 0.92, suggesting a potential issue
with the nal concentration. Agarose and PVA are found to have good quality relaxivity ts,
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(a) MnCl2 July 16 (b) MnCl2 Nov 17
(c) MnCl2 Nov 17 (d) MnCl2 R1 relaxivity
Figure 3.9: TR plots and resulting relaxivity estimation for MnCl2. The multiple TR plots
relate to multiple acquistion instances.
with R2 greater than 0.95 in all cases. Agarose is the strongest R2 modier of the gels, with
an almost tenfold increase in relaxivity compared to PVA, whilst maintaining a comparable
r1. The dierences in agar and agarose relaxivities appear to reect the agar impurities as a
primarily R1 modier, with the agarose as the source of agar's R2 relaxivity. For the contrast
agents, Gd2O3 produces the strongest relaxivity in both r1 and r2, and appears to aect both
R1 and R2 in equal measure. Conversely, MnCl2 produces a r2 approximately 10 times that
of its r1. The contrast agent phantoms generally exhibit good long term stability, within 95%
condence intervals. However, the 2016 MnCl2 r2 session is a notable exception, exhibiting
a 50% shift in r2 compared to the subsequent acquisitions. Surprisingly, a similar eect is
not observed in the r1 data. So, while the r2 increase may be indicative of gel degradation
39
(a) Gd2O3 TE t (b) Gd2O3 R2 relaxivity
Figure 3.10: TE plots and resulting relaxivity estimation for Gd2O3.
following the rst session, further study is necessary to elucidate the underlying process.
Repeat r2 scans of the Gd2O3 phantoms could aid this endeavour, and will be considered for
future work.
Table. A.2 contains the results of the two R2 scans, separated by a year. PVA results
are omitted from this table due to their visible deterioration. The PVA gels were observed
to disintegrate within days of the original scans, and provided a low MR signal when res-
canned. The agar and agarose appear visibly unchanged after a year, retaining their original
consistency. These results suggest good long term stability of agar and agarose, even when
stored at room temperature.
3.5 Conclusion
Agarose and PVA produce the best quality relaxivity ts in terms of R2, with agarose as a
primarily R2 modier. The R1 are comparable, but the relatively complex procedure involved
in the preparation of PVA will inevitably limit its use. Agar and agarose gels require a simpler
| and therefore more reproducible | preparation procedure, making them the better choice
for a stable phantom recipe. Variation in the composition of the agar make it a less precise
and reliable R2 modier. While agarose is preferable for control of R2, agar's reduced price,
increased availability, and good long term stability make it a viable alternative. Determining
the best gel is a subjective endeavour, and will vary by application. For example, although
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(a) MnCl2 July 16 (b) MnCl2 Nov 17
(c) MnCl2 Nov 17 (d) MnCl2 R2 relaxivity
Figure 3.11: TE plots and resulting relaxivity estimation for MnCl2. The multiple TE plots
relate to multiple acquistion instances.
agarose was able to produce relaxivity ts with high R2, it will inevitably vary more with
respect to R2 due to it's higher r2 relaxivity, making it unsuitable for some applications.
Both MnCl2, and Gd2O3 display consistent r1 relativities over extended periods of storage,
with R2 exceeding 0.94 in all cases. However, MnCl2 r2 relaxivity does reveal some tem-
poral instability, with gradient estimations increasing from 102:6 s 1 mmol 1 in July 2016,
to around 150 s 1 mmol 1 in November 2017. Degradation of the gels prevents a similar
analysis from being performed with the Gd2O3, so further work is needed to explore this
contrast agent.
Further work can be done in this area. The reproducibility of the gel creation process,
while apparent in the relaxivity, is not studied in great depth here. To expand on this
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(a) R1 relaxivity, r1.
Agent r1 s
 1 mmol 1 R2
Agar 0.0354 (0.0166, 0.0543) 0.8721
Agarose 0.0222 (0.0159, 0.0286) 0.9594
PVA 0.0380 (0.0188, 0.0571) 0.9984
Gd2O3 Sept 16 197.1 (152.7, 241.4) 0.9516
Gd2O3 Jan 18 195.1 (149.6, 240.7) 0.9483
Gd2O3 Jan 18 177.8 (138, 217.6) 0.9635
MnCl2 July 16 12.48 (10.37, 14.59) 0.9788
MnCl2 Nov 17 11.64 (9.059, 14.22) 0.9641
MnCl2 Nov 17 11.79 (9.185, 14.39) 0.9644
(b) R2 relaxivity, r2.
Agent r2 s
 1 mmol 1 R2
Agar 2.522 (-0.0686, 5.113) 0.6462
Agarose 6.583 (6.07, 7.096) 0.9969
PVA 0.7276 (-1.254, 2.71) 0.9561
Gd2O3 252.8 (216.2, 289.3) 0.9795
MnCl2 July 16 102.6 (87.23, 117.9) 0.9834
MnCl2 Nov 17 143.4 (116, 170.9) 0.9731
MnCl2 Nov 17 152.3 (114.3, 190.3) 0.9551
Table 3.1: R1 and R2 relaxivities for the pure gels and contrast agent series. relaxivities
are reported in s 1 mmol 1, with 95% condence intervals, and R2 t errors.
work, multiple independent copies of a particular gel concentrations should be made and
characterised. This phantom set could then be used to quantify the temporal stability of
the gels, with repeated rescans at regular time intervals. This would also facilitate the
determination of eective shelf life of the gel phantoms. There are also other contrast agents
that have been used in literature, for example, sodium chloride, and copper sulphate, and
carrageen as an alternative gelling agent.
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4 T1 mapping: what are we measuring?
4.1 Introduction
Tissue relaxation rates are of fundamental importance in magnetic resonance, as the primary
source of image contrast in conventional MRI. In addition to T1 and T2 weighted imaging [56]
(T1w, T2w), dierences in longitudinal (R1 = 1=T1) relaxation rates are also exploited to
suppress unwanted signals, e.g. to null the signal from water or fat proton using inversion
recovery sequences [57]. Although these techniques use relaxation weighting, optimal choice
of sequence parameters inherently requires knowledge of tissue relaxation rates [58]. Abso-
lute quantication of relaxation rates can also be advantageous when compared to relaxation
weighted techniques to minimize or eliminate potentially confounding eects of other vari-
ables such as variations in proton density or hardware factors such as eld inhomogeneity or
coil sensitivity [34,59,60].
Relaxation times are also biomarkers in their own right. Quantication of R1, which is the
main focus of this chapter, has many applications including cardiac R1 mapping [61,62] for
myocardial pathology [63], liver brosis [64] and cirrhosis [65]. Other important applications
for R1 mapping include dynamic contrast enhanced (DCE) MRI, a technique which aims
to model the uptake of an injected contrast agent over time by observing the change in
R1. The Tofts model [66], used in the prostate [67] for example, requires R1 mapping in
order to generate uptake information. A related application is the assessment of the safety
of Gadolinium-based contrast agents, which has recently been called into question due to
evidence of Gd deposition in tissue such as skin, bone and brain [68, 69]. Accurate R1
mapping could be a useful tool for non-invasively investigating Gd deposition over time,
periodically mapping tissue R1 values to quantify changes in relaxation rate.
However, a major issue is the large discrepancy in R1 values reported in dierent studies.
A recent review by Bojorquez et al. shows that reported R1 values for particular tissue types
vary greatly. While grey and white matter remain contrasted, the reported R1 can still vary
by as much as a factor of two [10]. Some dierences in measured R1 rates may be due to
physiological dierences in the volunteer populations studied, a problem compounded by
the small populations sizes in many studies. Furthermore, while R1 rates should in theory
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be intrinsic tissue parameters, there are many potential external factors that can aect the
results from hardware considerations such as the eld strength of the scanner [70, 71], to
the choice of mapping sequences and analysis procedures [72]. With regard to the former,
multi-site studies by Deoni et al. and Bane et al. found that for a given cohort of volunteers
and a xed acquisition and analysis protocol, the intra-site variation of R1 and R2 values is
on the same order as inter-site variation [32,73].
The focus of this study is to examine the latter source of variation, the eect of the R1
mapping protocols. While a wide range of R1 mapping protocols have been used in pub-
lished studies, the majority of them fall in one of three categories, which will be compared in
this chapter: inversion recovery (IR), saturation recovery (SR) and fast acquisition variable
ip angle methods (VFA). R1 quantication using IR mapping is often considered the most
accurate method for R1 quantication, followed by saturation recovery methods [10]. How-
ever, both of these methods require repeated acquisitions while varying TI or TR respectively,
rendering them time consuming and impractical for most clinical applications. This has lead
to the development of fast acquisition methods based on varying the ip angle. One of the
rst, the Look-Locker inversion recovery sequence [74], decreases the acquisition time of a
standard inversion recovery sequence by applying several low ip angle pulses to enable mul-
tiple signal acquisitions within a single repetition time. More recent VFA methods [75, 76]
reduce acquisition times even with ultra-fast spoiled gradient echo measurements.
The goal of this study is to compare three major types of R1 mapping sequences and as-
sess to which extent variations in the measured R1 values can be attributed only to dierent
acquisition protocols. To achieve this, dierent acquisition protocols are tested for R1 con-
trast phantoms and a small cohort of three volunteers under controlled conditions designed
to minimize eect of other factors such as hardware issues or physiological dierences.
4.2 Theory
Saturation recovery was covered in detail in the previous chapter, so will be omitted from this
section. The basis for inversion recovery and variable ip angle methods will be introduced
here. The IR pulse sequence (Fig. 4.1) begins with an 180 inversion pulse, then after time
TI , a 90
 pulse is applied. Phase and frequency encoding is applied, along with a refocussing
44
pulse, with the spin echo formed at time TE after the 90
 pulse. During TI , the system will
undergo T1 relaxation, returning back from inversion to equilibrium. At some point during
this process, Mz will be approximately zero. If the 90
 pulse is applied at this time, the
system will not produce a signal during acquisition. This eectively allows certain tissues to
be suppressed based on their T1. Inversion recovery is often considered the \gold standard"
for T1 quantication, superior to saturation recovery, due to its larger dynamic range.
Figure 4.1: Inversion recovery pulse sequence diagram.
R1 quantication using IR, again requires repeated acquisition of the sequence, this time
with TI varied. Consider a pair of unique pulses with ip angle 1, and 2, separated by an
inversion time, TI . The z-magnetisation before 2 determines the observed signal at readout:
Mz(2) = M0
1  (1  cos 1)e TI=T1   cos 1e TR=T1
1  cos 1 cos 2eTR=T1 : (4.1)
If 1 is assumed to be 90
, and 2 is set to 180 , Eq. (4.1) becomes:
Mxy = S0
 
1  reTI=T1 + eTR=T1 ; (4.2)
where r is some error factor resulting from imperfect refocussing pulses, and Mxy is extracted
from the dicom signal intensity, S0, r, and T1 may be determined as t coecients. The
eTR=T1 term is a constant, as TR is xed. Repeated acquisitions with a variety of TI 's will
build the characteristic \bounce curve" of IR relaxometry, shown in Fig. 4.4.
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The VFA methods consist of two or more acquisitions of a spoiled gradient echo sequence
(Fig. 2.5), with xed TR and TE. In this analysis method, it is the applied ip angle, , that
is varied. For a xed TR and TE we can write the transverse magnetisation as:
Mxy() = S0
sin
1  E cos; (4.3)
with E = exp( TR=T1) we can dene a system of linear equations in S0 and E, dening an
error vector, e.
e =
0BBB@
sin1 Mxy(1) cos1
...
...
sinn Mxy(n) cosn
1CCCA
0@S0
E
1A 
0BBB@
Mxy(1)
...
Mxy(n)
1CCCA : (4.4)
If there are exactly m = 2 dierent ip angles then there is generally a unique solution
with e = 0. For m > 2 the system is overdetermined and we minimize the least-squares
error or L2 norm of the error vector e to determine S0 and E from which we can infer
R1 =   ln(E)=TR. VFA methods are much faster than SR and IR, requiring as few as two
acquisitions. However, the T1 estimation requires a uniform ip angle across the entire region
of interest, so as to attribute any signal variation solely to T1. This is dicult to achieve, as
B1 inhomogeneity will always be present to some degree. For this study, all VFA scans were
conducted on uniform agar phantoms to reduce the eect of B1 inhomogeneity
4.3 Materials and Methods
4.3.1 Test objects and subjects
A concentrated solution of manganese chloride was made by dissolving 0:1 g manganese
chloride tetrahydrate (98%) in 1 l of deionized water. The concentrate was then further
diluted, to varying degrees, to create a series of seven 100 ml solutions with manganese
chloride concentrations of 0, 10, 20, 30, 40, 50, and 60 mg l 1, where 10 mg l 1 corresponds
to a 0:0505 mmol concentration of MnCl2. This range was selected | following a preliminary
investigation | to maximise the range of concentrations, while maintaining acceptable signal.
After scanning the solutions using the protocols described in Sec. 4.3.2, 1 g of agar was
added to each solution, to create 1% agar gels. 0:1 g of diazolidinyl urea was also added as
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a preservative at this stage. The solutions were heated to approximately 90 C and stirred
until the agar was fully dissolved and then allowed to cool and set overnight before being
rescanned using identical protocols.
To obtain in vivo data, three healthy volunteers, two males and one female aged 24-32,
were recruited to undergo brain scans with dierent R1 mapping protocols. One volunteer
returned for a second session the following day, where the protocol was repeated. This
provided an opportunity to compare intra, and inter-participant variation.
4.3.2 MR Protocols
All scans were conducted on a Siemens 3T magnetom Skyra scanner at Swansea university.
The scanner is situated in an air-conditioned environment kept at a temperature of 20 C.
Manual shimming and transmitter calibration were performed prior to all data acquisition
scans to minimize eects of B0 and B1 inhomogeneity.
Phantom scans The seven phantoms were placed in a hexagonal arrangement around
the isocentre of the magnet above the four channel spine coil element SP2. Again, SP2 was
selected to maximise the reproducibility of the phantom setup. For the IR and SR protocols,
a single 2 mm thick coronal slice through the centre of the phantoms was selected and all
images were acquired with a 256 256 mm eld of view (FOV), matrix size 128 128, pixel
bandwidth 130 Hz=px, 100% phase resolution, and one average. The SR protocol consisted
of acquiring a series of images with a vendor-supplied 2D spin echo (SE) sequence, comprised
of a 90 excitation pulse followed by a 180 refocusing pulse with xed TE of 12 ms, and TR
= 75 ms, 125 ms, 250 ms, 500 ms, 750 ms, 1000 ms, 1500 ms, 2000 ms, 3000 ms, 4000 ms and
5000 ms. For the IR protocol a vendor-supplied 2D SE sequence with an additional inversion
pulse prior to the excitation pulse was used, with a xed TR of 2500 ms, TE of 15 ms, and
TI values of 30 ms, 70 ms, 100 ms, 150 ms, 300 ms, 700 ms, 1000 ms, 1500 ms and 2000 ms.
The VFA protocol consisted of applying a vendor-supplied 3D spoiled gradient echo (GE)
sequence with TR = 4:09 ms and TE = 1:39 ms for a range of ip angles between 2
 and 90.
Twenty 2 mm thick coronal slices were acquired and a slice through the centre, matching
the slice chosen for the SR/IR protocols, was selected for the analysis. The FOV was 256
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256 mm, matching the IR/SR protocol, while for the matrix size and readout bandwidth,
the default values from a clinical protocol of 192  154 and 390 Hz=px, respectively, were
used. One series was also acquired with a longer TR of 14 ms for comparison. For each ip
angle 8 averages were acquired.
In vivo scans All volunteers were scanned using identical protocols in a 32 channel phased-
array head coil, this choice provided the best SNR for whole-brain imaging. To ensure
coverage of the entire head, 21 slices with of thickness and spacing of 5 mm were acquired.
The imaging plane was oset from transverse to coronal by 25. The FOV was 192256 and
the matrix size 128 96. 96 phase encoding steps and a per pixel bandwidth of 130 Hz=px.
The SR protocol used a vendor-supplied SE sequence with xed TE of 15 ms and TR of 286,
350, 550, 885, 1000, 2000, 4000 ms. The IR protocol used a vendor-supplied SE sequence
with an additional inversion pulse with TR = 2500 ms, TE = 15 ms and inversion times of
100, 400, 700, 1000, 1300, and 1600 ms.
4.3.3 R1 estimation
In-house developed Matlab software was used to analyze the scan data. For the phantom
data, delineation of the regions of interest (ROIs) was automated by thresholding the signal
from one reference image, identifying the connected components, and tting circular ROIs for
each component. Approximately 10% of the phantom's extent was excluded so as to limit
signal variation at the interface with the phantom's container, and both single voxel and
mean-signal-over-ROI ts were performed. For the brains, square ROIs corresponding to the
cerebellum and thalamus were selected manually, as illustrated in Fig. 4.2. Grey and white
matter regions were identied for a representative slice in the centre of each volunteer's brain.
For this slice, the thalamus was manually identied and removed from analysis, along with
boundary regions with the skull. The remaining voxels were assumed to be some distribution
of grey and white matter. A single voxel analysis was performed on each phantom, ROI, and
representative slice, resulting in an R1 value for each voxel in the region. Fig. 4.3 shows the
R1 distributions for an image, IR R1 map, and an SR R1 map for one of the representative
slices. The IR maps exhibit a bi-modal distribution in R1, with the modes corresponding
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to the R1 distributions of grey and white matter respectively. Image processing | using
a combination of thresholding and connected component analysis | was applied to the IR
maps in order to separate grey and white matter regions for independent analysis.
Figure 4.2: Delineated regions of interest for one of the patient cohort. One slice is se-
lected to delineate the cerebellum, and a second for the thalamus.
SR and IR curve tting was carried out with a trust-region-reective least-squares min-
imisation algorithm, using the Matlab curve tting toolbox with custom t functions dened
according to Eq. (3.1) and Eq. (4.2) respectively. The quality of each t is assessed using the
R2 value. The VFA t quality was assessed by determining the L2 norm of e in Eq. (4.4).
4.3.4 Statistical Analysis
For statistical purposes, single voxel ts were performed for each voxel inside the selected
ROIs for both phantom and brains. This results in a distribution of R1 values for each
ROI. Assuming the values are normally distributed, we can calculate a mean and standard
deviation of R1 for each ROI. We test the distribution for normality by calculating the
Kolmogorov-Smirnov [77] score. The overlap between the histograms for dierent ROIs yields
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(a) Histogram of contrast distributions for image and R1 maps for a single volunteer
and slice.
(b) Example of grey and white matter delineation for one volunteer.
Figure 4.3: The only histogram that displays a bi-modal distribution of R1 values is IR.
Hence this was used for delineation. The thalamus region was manually excluded, and the
grey and white matter separated using image processing.
information about how distinguishable the R1 values for dierent ROIs are. To establish
whether there is a statistically signicant dierence between the means in theR1 distributions
obtained for the same phantom or brain ROI with dierent R1 mapping methods, a two-
sample t-test [78] is performed and p-value and condence interval for the estimated dierence
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in the means for the R1 distributions is determined.
For the R1 contrast phantoms, both liquids and gels, R1 should increase linearly with
the concentration of the contrast agent. Therefore, we also plot the mean and standard
deviation of the R1 values as a function of the concentration of manganese chloride and
perform a linear t to determine the slope of the line, which corresponds to the relaxivity
of the contrast agent, enabling us to compare not only the R1 value, but also the resulting
relaxivity of contrast agent obtained for dierent R1 mapping methods.
4.4 Results
The R1 values for the liquid and gel phantoms obtained with dierent methods are tabulated
in Tables 4.1 and 4.2. The mean and standard deviation were calculated from the distribu-
tions of the single voxel ts for each phantom. The tables clearly show signicant variation in
the R1 values obtained for the same phantom using dierent methods. To further elucidate
the magnitude and signicance of the dierences in the R1 means, we performed pairwise
t-tests on the R1 distributions obtained with dierent methods for the same phantom. The
results tabulated in Table 4.3.
Comparing the SR and IR protocols, the dierences in the means of the distributions
were larger for phantoms with lower concentrations of MnCl2. For the VFA method, the
dierences in the R1 means for dierent VFA protocols were smaller, but they diered
signicantly from the estimates obtained with the SR and IR protocol. For phantoms with
low concentrations of MnCl2 the R1 values obtained for the VFA methods, especially the
common two-point method with ip angles 2 and 15, were much closer to SR values than
IR values, while the situation was reversed for higher concentrations of the contrast agent.
Non-negligible dierences in the R1 values obtained for the same phantom are also evident
in the relaxivity plots in Figure 4.5, which show that the R1 values obtained for the IR
protocol are consistently higher than the corresponding values obtained with the SR protocol,
although the dierences decrease slightly with increasing contrast agent concentration. This
is the case for both the liquid and gel phantoms although the dierences for the gel phantom
are somewhat smaller. Similarly, the R1 values for the two-point VFA method start close to
the values for the SR protocol for low concentrations of MnCl2 but for high concentrations
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(a) SR - solution (b) IR - solution
(c) SR - gel (d) IR - gel
Figure 4.4: Relaxivity curves for MnCl2 solutions and gels
exceed the R1 values obtained for the IR method. These dierences aect the slope of the
linear regression line, which corresponds to the relaxivity of the contrast agent, resulting
in dierent estimates for the relaxivity (see Table 4.4) although the overlap of the 95%
condence intervals of the estimates suggests that data for more phantoms with possibly
a wider range of concentrations would be required ascertain if the dierences in relaxivity
estimates are signicant at the 95% condence level.
Further details can be found in Appendix B. Figures B.2 and B.4 show the IR and SR
image series with ROIs selected and the R1 map obtained for the liquid and gel phantoms,
respectively. Fig. B.1 shows the images for an ultrafast ip angle series with TR = 4:09 ms
and the corresponding R1 maps obtained using two and nine ip angles, respectively. For
the IR and SR protocols, the corresponding transverse magnetization signal (mean and
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IR - solution SR - solution IR - gel SR - gel
Conc R1  R1  R1  R1 
(mmol) (Hz) (Hz) (Hz) (Hz) (Hz) (Hz) (Hz) (Hz)
0.0000 1.5332 0.033396 0.27012 0.017031 1.5798 0.019794 0.95521 0.027487
0.0505 1.6774 0.027502 0.70731 0.029947 1.683 0.11854 1.1378 0.039074
0.1011 1.7417 0.018924 1.2977 0.055165 2.4426 0.029179 1.8228 0.070709
0.1516 2.5027 0.029774 1.5187 0.036961 2.8013 0.039291 2.2092 0.078524
0.2021 2.7653 0.035631 1.9646 0.048536 3.0858 0.0418 2.6745 0.10494
0.2526 2.9866 0.04034 2.6034 0.096198 3.3651 0.045296 3.3335 0.13628
0.3032 3.219 0.045863 2.7624 0.07993 3.6218 0.066539 3.5571 0.43442
Table 4.1: Mean values of single voxel R1 ts, R1, and standard deviation,  obtained via
Inversion recovery (IR) and saturation recovery (SR) for solution and gel MnCl2 phan-
toms.
9-Point TR = 4090 12-Point TR = 14000 2-Point TR = 4090 2-Point TR = 14000
Conc R1  R1  R1  R1 
(mmol) (Hz) (Hz) (Hz) (Hz) (Hz) (Hz) (Hz) (Hz)
0.0000 1.0041 0.043723 0.78626 0.097955 1.0269 0.044152 1.0784 0.044892
0.0505 1.459 0.12399 1.2705 0.15092 1.4792 0.12086 1.5916 0.16318
0.1011 1.6947 0.11322 1.5305 0.14603 1.7282 0.11675 1.816 0.11493
0.1516 2.6534 0.19661 2.5533 0.20884 2.6694 0.2025 2.7525 0.21346
0.2021 3.0815 0.18991 3.2119 0.22549 3.0869 0.19886 3.2377 0.26769
0.2526 3.2353 0.17847 3.2976 0.18677 3.2784 0.19627 3.3791 0.22033
0.3032 4.3828 0.36785 4.4967 0.47059 4.4158 0.3849 4.5358 0.41844
Table 4.2: Mean values of single voxel R1 ts, R1, and standard deviation,  obtained for
VFA methods. For the two-point method ip angles of 2 and 15 were used. For the 9-
point method with TR =4:09 ms the ip angles were 2, 3, 4, 6, 8, 10, 12, 13 and 15 degrees.
For the 12-point method with TR =14 ms the ip angles were 2, 5, 10, 15, 20, 30, 50, 60,
70, 80 and 90 degrees.
standard deviation) as a function of TR and TI , respectively, with the best-t curves, is
shown in Figures B.3 and B.5 for dierent concentrations of the contrast agent, for both
liquid and gel contrast phantoms. Although only the mean signal ts are shown, they are
representative of the single voxel ts. The quality of the non-linear ts of the saturation and
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MnCl2 CI IR-SR Sol CI IR-SR Gel CI IR-VFA2 Gel CI SR-VFA2 Gel
0:0000 mmol (0:6215; 0:6277) (1:2596; 1:2665) (0:5568; 0:5627) ( 0:0683; 0:0615)
0:0505 mmol (0:5337; 0:5567) (0:9664; 0:9739) (0:2042; 0:2300) ( 0:3358; 0:3204)
0:1011 mmol (0:6127; 0:6269) (0:4387; 0:4494) (0:7515; 0:7626) (0:1291; 0:1454)
0:1516 mmol (0:5840; 0:6002) (0:9797; 0:9884) (0:1495; 0:1735) ( 0:4442; 0:4171)
0:2021 mmol (0:4008; 0:4217) (0:7952; 0:8063) (0:0101; 0:0349) ( 0:4040; 0:3735)
0:2526 mmol (0:0184; 0:0449) (0:3736; 0:3928) (0:1588; 0:1781) (0:1215; 0:1521)
0:3032 mmol (0:0242; 0:1052) (0:4480; 0:4650) ( 0:7717; 0:7251) ( 0:8590; 0:7672)
Table 4.3: Pairwise t-test results (allowing for dierences in variance) for R1 distributions
obtained with IR, SR and VFA 2-15 protocols for dierent phantoms show signicant dif-
ference. CI denotes the condence intervals for the estimated dierence in the means of
the two R1 distributions. The p-values for all tests were < 0:001, strongly rejecting the
null hypothesis that the R1 values come from the same distribution.
Figure 4.5: Relaxivity plot of MnCl2 gel phantoms comparing IR, SR and 2-15 VFA proto-
cols.
inversion recovery curves obtained was high: the majority of the single voxel ts have R2
values  0:99, and the percentages of single voxel ts with R2 < 0:95 are low at 1:2%, 2:5%,
15:1% 0:02% for IR gel ts, SR gel ts, IR solution ts and SR solution ts, respectively.
Although dierences in signal intensity are visible in the images, it is dicult to reliably
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Protocol relaxivity (95% CI) y-intercept (95% CI) R2 of t
Hz mmol 1 Hz
Solution-IR 6.155001(4.532139 , 7.777863) 1.4145(1.1184 , 1.7106) 0.9498
Solution-SR 8.430966(7.342461 , 9.539262) 0.3103(0.1098 , 0.5108) 0.98729
Gel-IR 7.164342(5.640435 , 8.688249) 1.5685(1.2920 , 1.8449) 0.96715
Gel-SR 9.222606(8.015355 , 10.429857) 0.8434(0.6236 , 1.0631) 0.98722
9-Point 10.647558(8.292429 , 13.002687) 0.8863(0.4570 , 1.3156) 0.96432
12-Point 11.914182(9.400725 , 14.447430) 0.6424(0.1837 , 1.1010) 0.96736
2-Point, TR =4090 10.687140(8.411175 , 12.982896) 0.9060(0.4891 , 1.3229) 0.96649
2-Point, TR =14000 10.865259(8.549712 , 13.180806) 0.9806(0.5588 , 1.4024) 0.96677
Table 4.4: Relaxivity t coecients for each phantom scan including 95% condence inter-
vals, and R2 t error
distinguish all contrast phantoms based on a single image. The R1 maps dierentiate the
contrast phantoms much better. For all methods tested, all phantoms are mutually distin-
guishable in that the pairwise t-test for the R1 distributions for any two phantoms rejects
the null hypothesis that they come from the same distribution at the p = 0:01 level even
when allowing for unequal variances of the distributions.
Analysis of the distribution of R1 values for dierent phantoms and methods in Fig. 4.6,
however, shows that there are variations in the shape of the distributions for individual
phantoms and the degree of overlap for dierent phantoms. Considering the overlap between
the distributions, the SR protocol appears slightly worse in discriminating the phantoms with
the highest concentration of MnCl2 while our IR protocol appears slightly worse for the lower
contrast phantoms. Comparing the distributions for the IR and two-point VFA method also
shows that the distributions for the latter are much broader with greater overlap of the
distributions for dierent phantoms, which is also reected in the larger standard deviation
of the R1 values obtained with VFA methods (see Tables 4.1, 4.2).
Table 4.5 shows a summary of the R1 mapping results for dierent brain regions and
four in vivo data sets, corresponding to three dierent volunteers with volunteer 2 being
scanned twice on two consecutive days. IR sequences consistently report a higher R1 (lower
T1), irrespective of region or volunteer. Table 4.5 also shows the t-test p-values, a measure
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(a) IR Series (MnCl2 Solutions) (b) SR Series (MnCl2 Solutions)
(c) IR Series (MnCl2 Gels) (d) VFA Series (MnCl2 Gels)
Figure 4.6: Histogram of R1 values for obtained for MnCl2 phantoms with various meth-
ods. Each phantom is plotted separately; 0:0000 mmol (light-purple), 0:0505 mmol
(dark-blue), 0:1011 mmol (orange), 0:1516 mmol (yellow), 0:2021 mmol (dark-purple),
0:2526 mmol (green), 0:3032 mmol (light-blue).
of the probability of the observed separation being a result of a single distribution. All
reported p-values for the in-vivo SR and IR comparisons fell below 4:977 10 10, indicating
a strong separation of R1 distributions. IR scans test-retest stability, with R1 for the repeat
patient reproduced to at least one decimal place in all cases. However SR protocols do not
exhibit the same stability, with the inter-participant variation on the same order as the intra-
participant variation. Contrast is maintained in both sequences, but absolute quantication
of R1 appears more stable for the so called \gold standard" IR sequence.
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Saturation recovery Inversion recovery
ROI R1  R1  t-test p-value t-test CI
Cerebellum
0.54049 0.05005 0.65455 0.056634 2.3887e-13 (0.088926 , 0.139186)
0.55055 0.068363 0.7487 0.078851 1.7832e-17 (0.163442 , 0.232847)
0.57851 0.067102 0.72479 0.062519 4.114e-14 (0.115542 , 0.177005)
0.53432 0.089759 0.68661 0.089246 4.977e-10 (0.110214 , 0.194364)
Thalamus
0.45608 0.061248 0.78954 0.10613 9.7379e-22 (0.291310 , 0.375618)
0.58107 0.034651 0.91667 0.091879 2.1845e-24 (0.302634 , 0.368569)
0.65352 0.073932 0.90481 0.059448 2.0914e-24 (0.219731 , 0.282852)
0.64345 0.056831 0.98384 0.08896 2.9029e-27 (0.304899 , 0.375884)
Grey matter
0.31149 0.087768 1.2437 0.21282 0.0000 (0.943582 , 0.920757)
0.33376 0.10896 1.2126 0.26517 0.0000 (0.890516 , 0.867075)
0.41577 0.16546 1.2262 0.24268 0.0000 (0.822167 , 0.798673)
0.40791 0.26618 1.2125 0.28234 0.0000 (0.819749 , 0.789466)
White matter
0.46905 0.048106 1.8965 0.090815 0.0000 (1.432445 , 1.422388)
0.48283 0.063785 1.8917 0.090622 0.0000 (1.414607 , 1.403110)
0.63293 0.11223 1.8901 0.090139 0.0000 (1.264989 , 1.249338)
0.59634 0.06578 1.8224 0.06586 0.0000 (1.233771 , 1.218308)
Table 4.5: Mean values of single voxel R1 ts, R1, and standard deviation,  obtained via
Inversion recovery(IR) and saturation recovery(SR) for volunteer cohort. The results are
separated by region, then ordered by volunteer; volunteer 1, volunteer 2 scan 1, volunteer 2
scan 2, volunteer 3.
4.5 Discussion
Comparing the R1 relaxivity values obtained for our MnCl2 solutions with those reported in
the literature, we nd that the R1 relaxivity of 6:397 mM
 1s 1 for MnCl2 solutions reported
in [55] fall within the 95% condence interval of the R1 estimate obtained with our IR
protocol. Specically, our value obtained with the IR protocol is about 4% lower than the
value reported in [55], while SR relaxivity is almost 32% higher, and the discrepancies are
even greater for the VFA method. Even accounting for the fact that most of the scans were
done for gel phantoms | which have a higher relaxivity than the solutions | the IR results
suggest that the relaxivity of the 1% agar gels is approximately 16% higher than the value
for the solutions, but the relaxivity obtained for MnCl2 gels with the two-point VFA method
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(2,15) is approximately 67% higher than the value reported in [55]. While this may suggest
that the IR method is the most accurate, the study by Thangeval et al. was performed
using a similar IR protocol and a 3T Siemens scanner similar to ours, and we have found
excellent consistency in our phantom data when the same protocol is repeated with the same
phantoms on the same hardware.
Although each method of R1 mapping was able to discriminate between the dierent con-
trast phantoms, the spread and overlap of the distributions obtained for a single phantom
varied depending on the method used. More importantly, the large dierence in the means
and distributions of the R1 values for same phantom or tissue ROI, obtained with dierent
methods, suggests that R1 maps acquired with dierent methods can not be reliably com-
pared. Furthermore, it is observed that the variation of R1 values | for a particular region
of the brain | as a result of acquisition method is in fact larger than the variation from
region to region. This suggests that dierences in the R1 quantication method may be a
major factor in the large variability of the values reported in the literature.
It could also be argued that it does not matter if we measure the true R1, or even if there
is a true R1, provided that we have a protocol that is eective at discriminating dierent
tissue types, and gives results that are consistent and reproducible with a small margin of
error. However, this is problematic for quantitative MRI and quantication of biomarkers,
as the characteristics of a true biomarker should not be dependent on the MRI protocol or
hardware characteristics, aside from physical variables such as eld strength.
The discrepancies in the R1 values obtained using VFA methods in particular have im-
plications for many clinical applications. For instance in DCE, R1 values obtained using a
two-point (typically 2,15) VFA method are often combined with known relaxivities of the
contrast agent to model contrast agent uptake curves, e.g., using the Tofts model. Given
known relaxivities of free Gadolinium within a particular tissue, R1 mapping has the poten-
tial to provide absolute Gadolinium quantication for these regions.
The ndings of this study indicate that the choice of acquisition method aects not only
R1, but also the relaxivity. Relaxivity for the gel phantoms was found to vary between
7.16(5.64, 8.69) and 11.91(9.40, 14.45) s 1 mmol 1 for inversion recovery and 12-point VFA
respectively. This suggests that ideally, the uptake model should be chosen to match the
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desired R1 mapping method, so as to reduce misidentication of the contrast agent uptake
curves and free Gadolinium deposits. In practice, accuracy and precision must be balanced
with the eciency of the acquisition protocol. While VFA methods are more susceptible to
B0 and B1 inhomogeneities than the recovery methods, the drastic reduction in acquisition
time makes them the far more practical choice for methods such as DCE.
The review by Bojorquez et al. found R1 for grey matter was reported between 0.55, and
1:03 s 1. The in-vivo R1 values from IR were found to lie within this same range, however,
the SR were found to be lower. For white matter a range of 0.70 to 1:33 s 1 was reported
in the review, whereas the white matter R1 for this volunteer group were found to lie above
and below this range for IR and SR respectively. The large disparity between the IR and
SR values is a consistent nding of this study. For all regions and volunteers, the SR and IR
methods fell outside the bounds of standard deviation, with t-test p-values ranging from 0
to 10 10. IR R1 values are found to be consistently higher than SR for the same regions, in
agreement with the ndings of the phantom study. SR methods show poor reproducibility in
grey and white matter quantication, with inter-participant variation on the same order as
intra-participant variation. Conversely, the IR methods display consistent intra-participant
results, while maintaining inter-participant variation.
If dierent methods to determine R1 produce such dierent results, this raises the ques-
tion what we are really measuring. Is there a true R1 value that depends only on the
characteristics of the phantom or tissue examined, and if so what protocol gives the most
accurate results for a wide range of tissues?
4.6 Conclusion
While the temporal consistency of phantom data, and in-vivo IR maps is promising, the
marked separation of IR and SR maps is troubling, and emphasises the need for standard-
isation of protocols where possible. Comparisons of R1 measurements across acquisition
protocols should be done tentatively, if at all, to avoid invalid conclusions. This is of partic-
ular relevance to DCE scans, where two sources of contrast agent relaxivity are compared.
Our results suggest that this is not best practice, and that it might be preferable to use a
single sequence for both measurements of R1. In this particular study, variable ip angle
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measurements were limited to phantom data, and the aect of the combinations of ip angle
were not explored fully. Other sequences, such as Look-Locker etc., could also have been
considered, given more time. To expand our ndings, and further elucidate the protocol
dependence of R1, a multi site and eld strength study is likely required. Expansion of the
variable ip angle study, and the inclusion of more methods, will provide a more rigorous
investigation of this phenomenon.
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5 Quantication of edited magnetic resonance spec-
troscopy: a comparative phantom based study of
analysis methods.
5.1 Introduction
Magnetic resonance spectroscopy (MRS) is an analytical branch of MR which produces
spectra, rather than images. An in-vivo MR spectrum is composite signal containing the
frequency components of all observable spin systems. Through processing and analysis it is
possible to derive molecular concentration information from the spectra, allowing a snapshot
of the metabolic processes that are occurring. Fig. 5.1 shows an MR spectrum of a human
brain, acquired from a volunteer at Swansea University. Molecules within the brain may
be identied by their characteristic peaks, and even quantied relative to the others in the
spectrum. As such, MRS is a powerful diagnostic tool [79], providing complimentary data
to the structure-based imaging of MRI. MRS provides a non-invasive means to assess the
chemical composition of anatomy, invaluable for sensitive areas of the body, where biopsy
would be problematic. While the brain is the most common application, there are other
regions where it has benet e.g. assessment of cancer of the prostate [80, 81] and breasts
[82, 83], or quantication of fatty liver disease [84, 85]. MRS can also be utilised in the
diagnosis and treatment planning of cancers; it allows identication and staging of tumours
[86, 87], delineation of tumour boundaries to a higher precision than MRI [88], and the
dierentiation of cancer type [89].
The focus of this chapter is the detection and quantication of some the major MRS
signal generating molecules in the brain. Using basic spectroscopic sequences at 1.5 / 3
T, several metabolites are identiable. Depending on the choice of acquisition parame-
ters, these include choline (Cho), creatine (Cr), and N-acetylaspartate (NAA), glutamate
(Glu), glutamine (Gln), myo-inositol (Myi), lactate (Lac), alanine (Ala), as well as lipids
and macromolecular resonances. Short TE sequences will better detect short T2 molecules,
meaning sequence parameters will change depending on intended target. NAA is one of
the most abundant amino acids in the central nervous system, and produces the largest
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Figure 5.1: STEAM spectrum of a human brain. Labels indicate the locations of charac-
teristic peaks. Overlap with larger peaks makes the detection of lower concentration sig-
nals problematic. Frequencies are plotted right to left, by convention.
signal in the brain, as can be seen in Fig. 5.1. It produces a single peak at 2PPM, with
N-acetylaspartylglutamate (NAAG) at 2.04. Glu and Gln, are a pair of amino acids with
very similar peaks, that are indiscernible with basic spectroscopy sequences, and are often
identied as one combined peak shape, Glx. Cr, a nitrogenous organic acid, is another
abundant signal generator, Cr produces a peak 3PPM, however this is again a composite
peak of Cr and phosphocreatine (PCr); a second resonance can be observed at 3.91PPM.
A less abundant, but no less important molecule, is GABA. Gamma-Aminobutyric acid,
or GABA, is the primary inhibitory neurotransmitter in the central nervous system, main-
taining the excitation{inhibition balance [90]. Its prominent role in both neurotransmission
and metabolism has led to extensive study, and a plethora of applications for its detection.
GABA has been observed to exhibit reduced uptake in Schizophrenic patients [91], GABA
receptor dysfunction has been observed in epilepsy suerers, and GABA related processes
have eects in the diabetic patients [92], and autism spectrum disorders [93]. GABA is also
the subject of intense study by the psychological community, with GABA processes inuenc-
ing impulsivity [94, 95], drug addiction [96], anxiety disorders [30, 97], and depression [98].
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However, despite its wide range of applications, there are many challenges in its detection.
GABA exists in the brain in mMolar concentrations, and relatively stronger signals, such as
NAA and Cr, will shroud those of GABA (Fig. 5.1). It is only through the use of edited spec-
troscopy [25,99{101], or other advanced techniques such as multi-dimensional spectroscopy,
making use of a larger parameter space [29, 30] that GABA becomes observable. The goal
of this study is to assess the robustness of GABA quantication using a calibrated phantom
study, and to compare some of the main analysis methods used for the quantication of
GABA edited spectroscopy. This work is intended as a precursor study for the development
of RF pulses for new techniques, Sec. 6, and new spectral decomposition methods, work be-
ing developed in conjunction with Max Chandler, and Frank Langbein of Cardi University,
Computer Science Department.
5.2 Theory
5.2.1 Spectral processing techniques
zero lling The FID of some sample is a signal of nite length, sampled at some discrete
rate. The resulting number of points in the FID will determine the spectral resolution of any
frequency domain spectrum. A relatively coarse sampling can be overcome using a process
known as zero lling. Zero lling is a signal processing technique that can increase the digital
resolution of a Fourier transformed spectrum. By appending the FID with additional zero-
valued components, the Fourier transform resolution can be increased accordingly. Zero
lling is comparable to an interpolation process which can increase SNR by a factor of
p
2 [102]. However, the process does not introduce any new information to the FID, so results
are still limited by the information content of the FID. Over-lling can also add additional
noise to the frequency domain spectra, further complicating the process of quantication.
Apodisation Another nuance of the Fourier transform becomes apparent when the start
and end points of the time-domain signal do not align. The Fourier transform interprets
this discrepancy as additional frequency components of the signal, introducing peaks to the
frequency-domain that should not be present. This process is independent of experimental
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procedure, and is still present in perfect sinusoidal composite signals. If the end point is
chosen to be a non-zero value, there will be additional peaks introduced in the frequency-
domain. This can be overcome using a process known as apodization. If we \window"
the time-domain signal, such that the end point is reduced to zero, we can eliminate these
additional peaks. This process can also be used to reduce noise in a spectrum. A standard
FID will usually require acquisitions on the order of seconds, by which point much, or all
of the signal will have decayed. After some time, the FID will no longer be enhancing the
signal peaks, but will only be adding to the noise of the spectrum. There are several options
in windowing, the simplest being a cut-o window, that involves selecting a point in the
FID | usually just after the major signal components have decayed | and then setting all
subsequent points to zero. This reduces the noise components, but will still contain Fourier
transform artefact peaks. Another, perhaps more commonly used example, is an exponential
window:
!(t) = e t=TW ; (5.1)
where TW is a weighting time-constant. When the FID is multiplied by an exponentially
decaying function, it reduces the weighting of the later points of the FID to zero. It also
provides a larger weighting to earlier points in the FID, resulting in an enhanced SNR.
However, when Fourier transformed, the resulting peaks will appear broader than in the
original spectrum, an eect known as articial line broadening. The Hamming window is
another option, oering similar benets. This function is given by:
!(t) = 0:54  0:46 cos

2
t
L  1

; 0  t  L  1; (5.2)
where L is the length of the window. There are also Hanning, Gaussian, and sinusoidal
windows, all of which can reduce noise, improve low SNR data, and remove Fourier transform
peaks, at the expense of peak broadening and arbitrary window length.
Singular-value decomposition The singular-value decomposition (SVD) is another method
that can be employed to lter spectra. The SVD is a generalisation of the eigenvalue de-
composition, a method of decomposing certain classes of matrices and representing them in
terms of their eigenvalues and eigenvectors. We can write a matrix, A, in terms of a singular
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value, , and singular vectors, u and v
Av = u; (5.3)
Ayu = v: (5.4)
Singular values are essentially a generalisation of eigenvalues. If our matrix, A has dimensions
n  m, we can dene an n  n matrix S = AyA. The singular values of A can be found
by taking the square root of the eigenvalues of S. If A is a square symmetric matrix with
positive, real elements, the singular values will in fact coincide with its eigenvalues. If the
singular values of A are compiled on the diagonal of an otherwise null matrix, , we nd:
AV = U; (5.5)
AyU = V : (5.6)
Eq. (5.5) can then give us the singular-value decomposition equation:
A = UV y; (5.7)
where U and V are square matrices, and  has the same dimensions as our general matrix,
A. Applying this to spectroscopy requires an additional step, the introduction of a Hankel
matrix in place of A. The Hankel matrix, H, is a symmetric, square matrix which is constant
across its skew-diagonals:
H =
26666666664
H1 H2 H3 H4 : : :
H2 H3 H4 H5 : : :
H3 H4 H5 H6 : : :
H4 H5 H6 H7 : : :
...
...
...
...
. . .
37777777775
; (5.8)
where, for spectroscopy, the HN are the N elements of the free induction decay. The singular
values, Sv, are acquired from the diagonal of the decomposed matrix, . Fig. 5.2 shows the
decomposition for an NAA, GABA, creatine phantom. Ordering the singular values by
amplitude and plotting reveals the disparity between the components. The spectrum is
composed of a few high amplitude components, which correspond to the major peaks in
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(a) Singular values ordered by magnitude. (b) Spectra reulting from specic lter length.
Figure 5.2: Singular value decomposition of an NAA/GABA/Cr phantom PRESS spec-
trum. In (a), singular values are ordered by amplitude and plotted, with singular values
beyond 10 converging to zero. This reected in the spectra in (b), with noise being added
after the initial 10 components.
the spectrum. Including the rst three components, for example, adds the water and NAA
peaks, as well as one of the creatine peaks, with subsequent components making successively
smaller contributions. Excluding singular values beyond a suitable threshold will remove
noise from the data, improving SNR. Unlike previous ltering methods, the SVD will not
broaden the peaks of the spectrum. However, its eectiveness at low SNR is dubious, as
peaks that are too close to the noise oor will be erroneously excluded, skewing the resulting
data.
Baseline subtraction Analysis of MR spectra may be further complicated by the presence
of a signal baseline; a background signal which interferes with the peaks of interest. A
uniform baseline, across the entire spectrum, can be easily removed by a simple subtraction,
however, many baseline signals will have a frequency dependent component. MRS in water
based media relies heavily on the suppression of water protons to be able to identify the other
signals. However, water suppression may not remove the entirety of this signal, and a residual
water baseline will be observed. This will introduce a frequency dependent modulation of
the signal, with peaks close to the water peak being articially augmented when quantied.
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Residual water subtraction is typically performed by a variation of the SVD method, the
Hankel Lanczos singular-value decomposition [103]. Another potential source of baseline,
in-vivo, are macromolecules and lipids, which can introduce a broad frequency dependent
baseline [104, 105]. This is often remedied by performing a linear, or polynomial t on the
signal oor of the data, which is then subtracted.
Frequency and phase correction Random noise will perturb any single FID, however,
over multiple acquisitions these uctuations will average out, and a single high quality spec-
trum can be obtained through the sum of individual FIDs. However, over the course of
multiple acquisitions, it is possible to observe changes that are not relevant for a single scan.
The temperature of gradient/RF coils, or that of the sample itself, can increase as a result
of the scans, causing a change in the reference frequency of the acquired FID. A similar
eect is observed in-vivo resulting from patient movement. The individual FIDs will be un-
changed | barring some peak broadening, perhaps | but the shift of the centre frequency
will manifest itself as a misalignment of the FIDs in the composite spectrum, resulting in
broader peaks, and a lower SNR. A similar issue is observed in the phase of a spectrum,
with the initial phase oset of a single acquisition unknown, a correction is required to avoid
SNR reduction, and peak broadening. Zero-order phasing adjusts a single spectral line, with
frequency dependent phase shift tackled by linear or rst order phasing. The relationship
between frequency and phase means the two issues are often linked, and corrected simul-
taneously for example, frequency and phase correction using residual water reference [106],
frequency and phase correction using spectral registration [107], and residual water peak
alignment, creatine tting, and spectral registration [108].
5.2.2 Quantication of spectra
Spectral line shapes contain not only information of the molecule structure, but also relative
concentration. Signals that are modulated by choice of TE, frequency, phase, baseline, and
noise can be corrected as discussed above, with remaining signal being indicative of concen-
tration. The signal, SM produced by NS scans of a molecule of molar concentration, M ,
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within a volume, V , is given by:
SM = NS G !0 M  V  fseq  fcoil; (5.9)
where R is the receiver gain, !0 is the Larmor frequency, and fseq and fcoil are complex
functions describing modulations due to sequence and coil respectively [12]. Some parame-
ters in this equation are unknown, for example, the signal modulation due the coils; direct
quantication of an MR signal is not possible. However, it is possible to calculate M relative
to some reference compound of known concentration, R;
M = R
SM
SR
CMR; (5.10)
where, SM and SR are the detected signals of the compound of interest and reference, re-
spectively, and CMR is a correction factor to account for dierences in relaxation properties,
, spatial variation etc. Calculation of CMR is often time consuming and impractical, so it
is far more common to simply report a concentration ratio, SM
SR
. Referencing can be per-
formed in one of two ways, externally, or internally. External referencing involves placement
of a phantom containing a known concentration of some reference compound, within the RF
sensitive region [109]. The reference solution must produce a stable, well resolved resonance
that does not interfere with the peaks being investigated. Care must be taken when using
this approach; phantom placement has a direct impact on RF homogeneity, and coil loading,
both of which can impact the observed signal. Internal referencing involves taking peak
ratios relative to one peak of the given spectrum. The peak chosen should be a well resolved,
strong signal that is stable with respect to time and environment. In-vivo, peak amplitudes
are commonly reported as a ratio of creatine or NAA, due to their relatively stable concen-
trations. The water signal may also be used as a reference compound [110], using estimations
of water densities of grey and white matter, for example, to estimate the concentration in
the voxel of interest. The relative impracticality of the external approach makes internal
referencing the far more common choice. Quantication of the signals themselves can be
done in a number of ways.
Numerical area tting The area of a particular resonance should scale linearly with
the concentration of the molecule that produced it, with the height of its constituent peaks
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scaling with the number of protons at that resonance. The simplest way to quantify this area
is numerical integration. An MRS spectrum is a discrete function, so is accurately quantied
by integral approximations such as the trapezium rule. However, small variations, such as
noise and baseline, will also be captured by this methods, so it can be preferable to t peaks
with a Lorentzian distribution function. Fitting a single Lorentzian is only feasible in the
case of an individual, resolved peak, so has limited applicability. A more general Lorentzian
tting technique can be used in conjunction with a least squares optimisation.
Least-squares tting It is possible to model an FID consisting of n signal values, yn, as
a sum of exponentially damped, complex-valued sinusoids, sampled at uniformly distributed
times tn = (n+ ) t; n = 0 : N   1:
yn =
KX
k=1
ckz
n+
k =
KX
k=1
ake
i(0+)e( dk+2ifk)tn ; (5.11)
where K is the model order, fk the frequencies, ak the amplitudes, dK the damping fac-
tors, 0 the zero-order phase, and k the individual phase adjustment [103]. A least-squares
minimisation algorithm is performed, the specic implementation of which will vary, to nd
the optimal set of parameters that model the spectrum, a process which is usually inde-
pendent of user interaction. Lorentzian components with a high amplitude, ak, contribute
more signicant peaks to the spectrum, and may be correlated to the constituent molecule.
Smaller amplitudes can similarly be regarded as noise, and discarded. There are limitations
to this method, especially for low SNR data. Prior knowledge, and user interaction is not
commonly implemented, so high levels of noise restrict the accuracy of the decomposition of
the spectrum.
Basis set tting Basis set tting methods take a similar approach to least-sqaures tting,
but dier in the choice of model function. Instead of representing the spectrum as an
arbitrary array of Lorentzian functions, a linear combination of a set of basis functions
is used. The basis | a set of spectra, one for each anticipated constituent molecule |
can be generated using calibrated phantom spectra, or via quantum mechanical simulated
data. This approach reduces the amount of misidentied noise, improves the resolution of
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interfering signals, and improves identication of molecules generating multiple resonances.
Some metabolites have a signal which depends upon the molecular environment, for example
NAA's PH dependence (Fig.5.6), or temperature based frequency shifts, Fig. 5.5, which can
actually be used to quantify temperature [16,111]. The basis set tting methods are unable
to account for such environmental changes, which leads to misidentication of metabolite
signals.
5.3 Materials and Methods
5.3.1 Phantom preparation
The phantom study consists of four experiment series | two solution, and two gel | where
the GABA concentration is varied over multiple acquisitions of a xed protocol. The two
solution series were prepared by dissolving the required concentrations of metabolites in
290 ml of de-ionised water. Table. 5.3 show the various metabolite concentrations. The
scan protocols were applied for each row in the table, with the solution adjusted between
scans. To reduce the uncertainty resulting from low weight metabolite changes, ner GABA
adjustments were made using a concentrated GABA solution, administered via a syringe.
In the second solution, pH monitoring was introduced, with adjustments made after each
metabolite change. These adjustments were made using a 36% hydrochloric acid solution,
and a <4% sodium hydroxide solution to maintain a pH of 7  0.3.
For the gel series, a set of solutions were made in advance of scanning, along with a
1% concentration of agar. The solution was then heated to between 80 and 90 while
stirred until the agar had dissolved. The solutions were allowed to cool over night in two
hemispherical moulds, which were combined once the mixture had almost set.
5.3.2 Scan protocols
All scan protocols were conducted at Swansea University's Clinical Imaging Facility using
a Siemens 3T Magnetom Skyra. The scanner room is temperature controlled to 20 C 
0:6 C. All scans were conducted at this temperature, however, the GLX series was also
heated to body temperature for a set of rescans to examine the eect of temperature shift in
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(a) Solution phantom (b) Gel phantom
Figure 5.3: Images spherical solution and gel phantoms.
NAA 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0
Cr 0.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0
GABA 0.0 0.0 0.5 1.0 1.5 2.0 2.5 3.0 4.0 6.0 8.0 10.0 11.6
Table 5.1: GABA1 - Solution series with xed NAA and Cr concentration, and GABA
varied. pH stabilisation is applied here, maintained to 7.0  0.2.
NAA 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0
Cr 0.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0
GABA 0.0 0.0 0.5 1.0 1.5 2.0 2.5 3.0 4.0 5.0 6.0 7.0 8.0 9.0 12.0
Table 5.2: GABA2 - Solution series with xed NAA and Cr concentration, and GABA
varied. No pH stabilisation was applied, resulting in an acidic solution.
NAA 15.0 15.0 15.0 15.0 15.0 15.0
Cr 0.0 8.0 8.0 8.0 8.0 8.0
Glu 12.0 12.0 12.0 12.0 12.0 12.0
Gln 3.0 3.0 3.0 3.0 3.0 3.0
GABA 0 1.5 3.0 5.0 7.0 10.0
Table 5.3: GLX - Gel series with xed NAA, Cr, Glu, and Gln concentration, and GABA
varied. pH stabilisation is applied here, maintained to be 7.0  0.2. Here, agar is used as
the gelling agent, at 1% concentration.
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the quantication procedure. Signal acquisition was done using the four channel spine coil
element \SP2". The phantom was aligned with this element, then raised to isocentre using
a custom phantom holder. This ensured the maximum eld homogeneity for the scans.
Double spin-echo interference eld maps were acquired to assess the homogeneity of the
phantom, then manual shimming was performed to optimise the spectral width. Double echo
(a) 290 mL solution phantom.
(b) 100 mL gel phantom.
Figure 5.4: Double spin echo B0 maps for solution and gel phantoms. The concentration of
fringes indicate homogeneity in the B0 eld, with large fringe spacing suggesting a homo-
geneous eld.
interference eld mapping is based on a double spin-echo sequence calibrated to maximize
interference between the regular and stimulated echo pathways. The refocusing pulses are
applied at times 1
2
TE and
3
2
TE. At time 2TE both a stimulated, and regular echo are produced
at readout. The phase dierence between the two echoes is determined by the TE, and is
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proportional to the precessional frequency dierence, f , and the eld inhomogeneity, ,
is:
 = 2fTE = BTE: (5.12)
Therefore the frequency dierence between two fringes in the image is: f = 1
TE
. Thus, if
TE = 20 ms, then the frequency dierence between two consecutive fringes is 50 Hz, while
for TE = 100 ms the dierence corresponds to 10 Hz. From the frequency dierence, we can
easily obtain the B0 eld inhomogeneity in Tesla by multiplying with the Larmor constant,
, of the nucleus. Double spin echo eld mapping is useful to quickly visualize the pattern
of the inhomogeneity. The eld maps are shown in Fig. 5.4 were acquired using TE of 20 ms.
The homogeneity of the solution phantoms, and their larger volumes, allowed isocentre voxels
to be selected in all cases, with inhomogeneous regions restricted to the neck of the ask.
Gel phantoms were found to have higher levels of inhomogeneity in the centre, due to the
gelling procedure used in this case. ROIs for the gels were selected outside of this region to
preserve the quality of the data.
5.3.3 Analysis methods
There have been many analysis tools developed for magnetic resonance spectroscopy data,
some of the major tools are presented here, along with their use within this study.
Tarquin Totally Automatic Robust Quantitation in NMR (TARQUIN) [113,114] is a time
domain basis set analysis tool. TARQUIN is a free to use software package complete with
GUI. Quantication is performed using the Lawson-Hanson non-negative least-squares al-
gorithm [115] to t a basis set generated by its custom NMR simulator, or a user dened
alternative. Residual water removal is performed using HSVD, and automatic phase and
frequency correction is applied. TARQUIN does not perform a full MEGA-PRESS simula-
tion, but rather models the expected signal, and adjusts its phase correction procedures to
accommodate the negative NAA peak. Frequency calibration is made relative to NAA, and
results are reported as t amplitudes.
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JMRUI JMRUI [116, 117] is a free software package for the processing and analysis of
MRS datasets. It was built upon its Matlab-based predecessor | magnetic resonance user
interface (MRUI) { developing a JAVA based UI for its software. JMRUI is a comprehen-
sive package which includes a variety of processing and quantication techniques. JMRUI
utilises several variations of singular value decomposition for processing and quantication,
including Hankel singular-value decomposition (HSVD) [118,119], Hankel Lanczos singular-
value decomposition (HLSVD) [103], Hankel total least squares (HTLS) [120], linear predic-
tion and singular-value decomposition method (LPSVD) [121]. JMRUI also includes \Ad-
vanced method for accurate, robust, and ecient spectral tting" (AMARES) [122] which
expands on a previous algorithm VARPRO [123]; a time-domain non-linear least-squares
method. AMARES uses the dn2gb algorithm [124] which improves on the performance Lev-
enberg{Marquardt algorithm of VARPRO under certain conditions [122]. AMARES also
changes its approach to prior knowledge imposition; implementing a singlet tting, rather
than multiplet. JMRUI also has two basis set quantication algorithms that make use
of its NMR simulation package, NMRSCOPE-B [125, 126]. NMRSCOPE-B is a quantum
mechanical simulation tool that can simulate metabolic, and arbitrary user-dened models
under inuence of a variety of common pulse sequences. The rst, \quantitation based on
semi-parametric quantum estimation" (QUEST) [127, 128], is a time-domain quantication
tool which is based on AMARES and VARPRO, and uses the Levenberg{Marquardt algo-
rithm. QUEST includes a semi-parametric approach to handle spurious signal resulting from
macro molecules and lipids. \Automated Quantitation of Short Echo time MRS spectra"
(AQSES) [129] is the second, a time domain basis set quantication package. AQSES uses
a modied VARPRO algorithm [130], with introduces the imposition of prior knowledge in
the form of upper and lower bounds on the nonlinear parameters. Macromolecular baselines
are tted non-parametrically using penalized splines.
For this study, the QUEST and AQSES algorithms were used to quantify the spectra.
A single MEGA-PRESS pulse sequence was dened in NMRSCOPE-B, with sequence pa-
rameters adapted to those of our experimental data. Two basis sets were generated, one for
the GABA/Cr/NAA, and one for the GABA/Cr/NAA/GLX. Manual frequency calibration
was performed, using the NAA peak as a reference. Results reported are the t amplitudes
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resulting from this process.
LCModel LCModel [131,132] is a Linux based black box MRS analysis tool. LCModel can
be used with its internal in-vitro basis, or with any arbitrary basis set specied by the user.
The baseline signal, resulting from macromolecules, is established using spline ts. Fitting
is attempted using the Gauss-Newton non-linear least-squares algorithm, with a Marquardt
modication [133]. For this study, LCModel analysis was performed in Cardi university
by Max Chandler due to the licensing restrictions of LCModel. The analysis was performed
with two user basis sets, one with the Govindaraju GABA model, and one with the Kaiser
et al. model. The details of the models are found in Appendix. C . Both sets of results are
reported in terms of their t amplitudes.
VeSPA Versatile Simulation, Pulses and Analysis package (VeSPA) [134] is a python based
amalgamation and extension of three software packages, MatPulse [135], GAVA [136], and
SITools [137]. VeSPA utilises the Voigt method | based on the papers by Young, Soher, et
al. [138,139] | an automated spectral analysis procedure that combines a parametric model
of metabolites with a non-parametric characterization of the unknown signal components.
The basis set is generated using the Python implementation of the GAMMA simulator;
PyGAMMA [140], and baseline estimates made using the residual signal. VeSPA is excluded
from this study, as their current MEGA-PRESS simulator is still under renement.
GANNET GABA-MRS Analysis Tool (GANNET) [141] is a black box Matlab based anal-
ysis tool, specically designed to process GABA MEGA-PRESS data. GANNET consists of
two separate modules, GannetLoad, and GannetFit. The rst module receives time-domain
data (and water un-suppressed spectra if available), performs channel combination, adds
line broadening, frequency and phase corrections, outlier rejection, and time averaging. This
structure can then be analysed independent of the tting module. The tting is performed
using non-linear least-squares algorithms (lsqcurvet and nlin). It uses a ve parameter
Gaussian model to estimate the 3PPM GABA signal in the dierence spectrum, a six pa-
rameter Lorentzian model to estimate the 3PPM Creatine signal in the o spectrum, and
if available, a six parameter Gaussian-Lorentzian model to t the unsuppressed water sig-
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nal. Quantitative results are then reported as integral ratios of GABA to Creatine, and a
concentration relative to water, NAA, or GLX.
In-house analysis As well as the popular tools, the data was analysed with in-house soft-
ware, written in Matlab. Zero lling was applied to four times the vector length. Frequency
corrections used the 2PPM NAA peak as a reference, and tting was applied. Numerical
integration, was applied within intervals, GABA = (2.88, 3.14), NAA = (1.9, 2.1), GLX1
= (3.66, 3.81), and GLX2 = (2.27, 2.44). This process was selected based on the analysis
of smaller preliminary experiments. Results suggested good performance, even compared to
the established tools, so this t procedure is included as a baseline for the experiment. The
results of this analysis are reported as peak area ratios.
5.3.4 Calibration
As stated previously, temperature has a direct eect on MR spectra, particularly the water
peak. The analysis tools we investigated are calibrated for in-vivo data, at body tempera-
ture. Our study is a room temperature phantom study, so care must be taken in frequency
calibration. To further elucidate the temperature dependence of the water peak, we per-
formed a calibration experiment using a water/DSS phantom. DSS is stable with respect to
temperature and pH, so is often used as a reference peak in NMR studies. A round bottom
ask was lled with 290 mL of deionized water, and 1 mmol of DSS dissolved within, and
the pH recorded at 6.97. The ask was heated in a water bath to 40 C, and placed in
the scanner, mirroring the set-up of the phantom series. A series of PRESS spectra were
acquired, with the temperature measured intermittently. The maxima of the water and DSS
were quantied, and the separation of the peaks recorded. Fig. 5.5 shows this separation
plotted against the mean temperature during the scan. The mean was calculated based on
the temperature recorded before and after the scan. Error in the maximum was estimated
based on the frequency resolution, while error in the temperature taken to be the separation
of the readings. The DSS-water peak separation was found to vary between 4.80, and 4.64
PPM, with a negative linear gradient of -9.676 10 3 PPM=C with 95% CI of (-10.11,
-9.246) 10 3 PPM=C, and R2 of 0.9910. With water used as the centre frequency for the
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Figure 5.5: The DSS peak is stable with respect to both pH and temperature, so any
change in the separation between the water and DSS peaks is a result of the water peak
shifting.
spectrometer, this shift of approximately 0.164 PPM from body to room temperature, will
be present in the peaks of all other metabolites. This is accounted for by referencing all
scans to NAA, aligning the large NAA singlet to its correct position of 2.00 PPM.
The NAA/Cr/GABA series was performed twice, once with pH calibration, and once
without. NAA is natively acidic, with a pH dependent spectrum. We postulated that ba-
sis set quantication would fail for phantoms outside the ph range expected in the healthy
brain. Fig. 5.6 shows dierence pH makes to the NAA spectrum. While the 2PPM NAA
peak remains stable, the secondary peaks are unrecognisable, a challenge for basis set meth-
ods. MEGA-PRESS simulations were performed using the FID-appliance (FID-A) [142], a
simulation and data processing package for MRS. MEGA-PRESS dierence spectra were
generated to mirror the sequence parameters of the phantom study, with nite-bandwidth
editing pulse alternating at 1.9 ppm and 7.4 ppm, at a eld strength of 2:89 T, bandwidth
of 1250 Hz, with two and four step phase cycling, and ideal refocusing pulses. Spectra were
generated for creatine, NAA, Glutamine, Glutamate, shown in Fig. 5.7, three of the most
commonly used GABA models, shown in Fig. 5.8. The dierence spectra were then com-
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Figure 5.6: NAA phantom spectra for neutral, and acidic pH, respectively. The main
2PPM singlet remains stable, but the secondary peaks change.
bined to reect the ratios of the phantom experiment, with the GABA concentration varied
between 1 mmol and 12 mmol at 1 mmol intervals, for both models. The combined spectra
were analysed with a peak integration, with the resulting four series shown in Appendix. D.
The GABA to NAA peak area ratio was plotted against the GABA concentration for the
GABA/Cr/NAA series, and the GABA/Cr/NAA/GLX series, Fig. 5.9 and Fig. 5.10, re-
spectively. The simulated NAA/Cr/GABA series produced a concentration gradient of
0.96, 1.00, and 1.00 for the Govindaraju, Kaiser and Near models, respectively. For the
NAA/Cr/GABA/GLX series, the gradient was found to be 0.93, 0.98, and 0.98 for the
Govindaraju, Kaiser, and Near models, respectively. The addition of GLX to the simulation
appears to make little dierence to the quantication of the gradient, however the intercept
of the concentration plots increases from -0.05 for NAA/Cr/GABA, to -0.03 for NAA/Cr/-
GABA/GLX. This can likely be explained by the 2.1 PPM GLX peaks. These peaks will
act to negate the negative NAA peak, reducing the constant scale factor on the GABA
concentration gradient. The dierence between the models appears small in this analysis,
especially comparing Kaiser and Near, however, numerical integration is relatively insensi-
tive to the eects of coupling. The model choice is anticipated to be more impactful for
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(a) NAA (b) Creatine
(c) Glutamate (d) Glutamine
Figure 5.7: FID-A simulations of relevant metabolites for phantom series.
basis set tting [143], where peak evolution is inuenced by coupling structure. The choice
of model will have further signicance in the subsequent chapter, with molecular structure
forming the basis of the methodology.
5.4 Results
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(a) GABA - Govindaraju (b) GABA - Kaiser (c) GABA - Near
Figure 5.8: FID-A simulations for the three most commonly employed GABA models.
(a) Govindaraju et al. (b) Kaiser et al. (c) Near et al.
Figure 5.9: Simulated GABA to NAA area ratio vs GABA concentration, for GABA/cr/-
NAA phantom, with linear t for the three common GABA models.
(a) Govindaraju et al. (b) Kaiser et al. (c) Near et al.
Figure 5.10: Simulated GABA to NAA area ratio vs GABA concentration, for GABA/cr/-
NAA/GLX phantom with linear t for the three common GABA models.
80
For each analysis tool, the spectra are decomposed into a set of areas or amplitudes,
as outlined in Sec. 5.3.3. The GABA amplitude alone will vary by acquisition, but taking
the GABA signal as a ratio to the stable NAA peak will improve the quantication. This
ratio is calculated for each tool, and plotted against the known concentration ratio of GABA
to NAA. A linear t is applied in each case, with the gradient and intercept extracted,
along with the R2 t error. Plots of available data are included here, and full t results are
tabulated in Table. 5.4, and Table. 5.5.
The R2 of the linear ts is found to vary by series, with well calibrated solutions exhibiting
the highest, and the gel series the lowest.
Figure 5.11: Measured GABA to NAA ratio vs known ground truth - GABA1.
Fig. 5.11 shows the linear ts for series GABA1. Perhaps the most notable feature of
this plot is the Tarquin data, which appears to overestimate the GABA gradient by almost
a factor of two. This is even more surprising when | with the exception of GANNET |
all other tools estimate the GABA gradient to be between 0.48, and 0.66. Tarquin does
however display good linearity, with an R2 of 0.98. Another notable feature is the intercept
of the JMRUI tools, QUEST and AQSES. While most tools are able to accurately ascertain
the lower concentrations of GABA, the JMRUI tools report a GABA signal, where none
is present. JMRUI also exhibits a lower R2 than the other tools: 0.65 and 0.68, versus a
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minimum of 0.93 for the others. While a lot of discrepancy between tools can be explained
by varying approaches to preprocessing, the disparity between AQSES and QUEST can
not. A common pre-processing was applied to each spectrum in JMRUI, so any dierences
between the two results are purely algorithmic in origin. For both solution series', LCModel's
basis sets agree up to 1 decimal place, a surprisingly robust result. This suggests that pre-
processing and algorithm have a larger impact than the basis set chosen. Fig. 5.12 shows
Figure 5.12: Measured GABA to NAA ratio vs known ground truth for the series GABA2.
the linear ts for the GABA2 series, where a low pH was maintained. Tarquin surprisingly
performs better in this series, estimating a GABA gradient of 0.99. While its R2 is lower, the
shift in the GABA gradient is appears to be a quirk of Tarquin's basis MEGA-PRESS basis
set. LCModel and GANNET both severely underestimate the GABA gradient, with slopes of
0.11, 0.13, and 0.24. The in-house Matlab based analysis maintains a high R2 for both series',
but underestimates the GABA gradient in both cases. For the in-house data, the analysis
was repeated for 1, 2, 4, and 8 times zero-lled data, with the four-times data displayed in
the gures, and full results in Table. 5.4, and Table. 5.5 Fig. 5.13, and Fig. 5.14 show the
linear ts for body, and room temperature, respectively. For the gel series, GABA gradients
and R2 are generally lower, as a result of the more challenging environment. Despite this,
Tarquin again over-estimates the GABA gradient, this time for room temperature series.
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Figure 5.13: Measured GABA to NAA ratio vs known ground truth for the series GLX at
body temperature.
Figure 5.14: Measured GABA to NAA ratio vs known ground truth for the series GLX at
room temperature.
LCModel performs poorly in the gel series', with R2 lower than 0.55 in all cases.
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Series Basis Gradient (95% CI) Intercept (95%) R2
GABA1 LCM - Gov 0.5279 (0.4873,0.5684) 0.0111 (-0.0034,0.0256) 0.9868
LCM - Kai 0.4756 (0.4437,0.5075) 0.0018 (-0.0096,0.0132) 0.9899
JMRUI AQSES 0.6699 (0.3662,0.9737) 0.4769 (0.3683,0.5854) 0.6817
JMRUI QUEST 0.5760 (0.2976,0.8544) 0.4860 (0.3865,0.5854) 0.6534
Tarqin 1.8511 (1.6879,2.0143) -0.0657 (-0.1240,-0.0074) 0.9826
Matlab x1 0.6440 (0.5394,0.7487) 0.0141 (-0.0233,0.0515) 0.9434
Matlab x2 0.6602 (0.5610,0.7594) 0.0012 (-0.0343,0.0366) 0.9512
Matlab x4 0.6607 (0.5624,0.7591) 0.0013 (-0.0339,0.0364) 0.9521
Matlab x8 0.6621 (0.5646,0.7597) 0.0008 (-0.0340,0.0357) 0.9530
Gannet3 -27.8761 (-89.2030,33.4506)103 15.1674 (-6.7416,37.0763)103 0.0834
Gannet3 excl 3 5 0.3396 (0.2730,0.4062) 0.0087 (-0.0171,0.0345) 0.9367
GABA2 LCM Gov red 0.1146 (0.0438,0.1854) -0.0035 (-0.0308,0.0239) 0.4626
LCM Kai red 0.1344 (0.0679,0.2009) -0.0073 (-0.0330,0.0184) 0.5731
JMRUI AQSES 0.9952 (0.7184,1.272) 0.2729 (0.1659,0.3798) 0.8094
JMRUI QUEST 1.042 (0.712,1.372) 0.2806 (0.1529,0.4082) 0.7660
Tarqin 0.9878 (0.7290,1.2465) 0.0232 (-0.0768,0.1232) 0.8272
Matlab x1 0.5499 (0.4593,0.6404) -0.0123 (-0.0473,0.0227) 0.9238
Matlab x2 0.5786 (0.5229,0.6343) -0.0210 (-0.0425,0.0005) 0.9726
Matlab x4 0.5769 (0.5211,0.6328) -0.0196 (-0.0412,0.0020) 0.9723
Matlab x8 0.5761 (0.5216,0.6306) -0.0183 (-0.0393,0.0028) 0.9735
Gannet3 0.2443 (0.1949,0.2936) 0.0082 (-0.0108,0.0273) 0.8894
Table 5.4: Linear t parameters for GABA1 and GABA2; the solution series. Gradients
and intercept are reported with 95% condence intervals, along with R2 t error.
5.5 Discussion
The results presented illustrate some of the shortcomings of some of the commonly used
analysis methods. While both Tarquin and LCModel perform well for the PH calibrated
solutions, when faced with the broader and noisier gel spectra, or the acidic solutions, they
begin to produce more inconsistent results. LCModel in particular demonstrates this, for
the GABA1 series, both basis sets have an R2 of 0.99. However, the gel series, LCModel is
unable to determine the gradient, with R2 less than 0.55 in all cases. This is particularly
worrying, as the gel phantoms more accurately represent the in-vivo environment in which
they are used. Tarquin does seem more robust with respect to these issues, but the large
range of reported gradients is an issue, ranging from 0.55 for GLX, up to 0.98 for GABA1.
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Series Basis Gradient (95% CI) Intercept (95%) R2
GLX LCM Gov red 0.1714 (-0.1589,0.5018) 0.0442 (-0.0965,0.1849) 0.4763
Body Temp LCM Kai -0.0058 (-0.4501,0.4385) 0.0774 (-0.1119,0.2667) 0.0006
JMRUI AQSES 1.135 (-0.6976,2.967) 0.3948 (-0.3165,1.1060) 0.4250
JMRUI QUEST 1.422 (0.2023,2.642) 0.3378(-0.1358,0.8115) 0.7237
Matlab x1 0.5218 (0.2433,0.8002) -0.0024 (-0.1106,0.1059) 0.8712
Matlab x2 0.5274 (0.2626,0.7923) -0.0044 (-0.1074,0.0986) 0.8843
Matlab x4 0.5328 (0.2609,0.8047) -0.0040 (-0.1097,0.1017) 0.8810
Matlab x8 0.5348 (0.2589,0.8107) -0.0038 (-0.1111,0.1034) 0.8787
Tarqin 1.1061 (-1.8532,4.0653) 0.1850 (-0.6548,1.0249) 0.3205
Gannet3 0.1574 (-0.0557,0.3705) 0.0300 (-0.0529,0.1129) 0.5124
GLX LCM Gov red 0.1002 (-0.0246,0.2249) 0.0267 (-0.0218,0.0752) 0.5541
Room Temp LCM Kai 0.0148 (-0.0039,0.0336) 0.0351 (0.0278,0.0424) 0.5474
JMRUI AQSES 1.135 (-0.3165,2.967) 0.3948 (-0.3165,1.106) 0.4250
JMRUI QUEST 1.422 (0.2023,2.642) 0.3378(-0.1358,0.8115) 0.7237
Tarqin 2.3385 (-0.4145,5.0914) 0.3122 (-0.7583,1.3828) 0.5817
Matlab x1 0.3665 (0.1063,0.6267) 0.0592 (-0.0420,0.1604) 0.7927
Matlab x2 0.3682 (0.1033,0.6332) 0.0610 (-0.0421,0.1640) 0.7882
Matlab x4 0.3662 (0.1051,0.6273) 0.0609 (-0.0406,0.1624) 0.7913
Matlab x8 0.3630 (0.1037,0.6222) 0.0612 (-0.0396,0.1620) 0.7907
Gannet3 0.1123 (-0.5081,0.7328) 0.1142 (-0.1271,0.3554) 0.0594
Table 5.5: Linear t parameters for GLX gel series at room and body temperature. Gradi-
ents and intercept are reported with 95% condence intervals, along with R2 t error.
The JMRUI results present a useful window into the algorithmic dependence of the quan-
tication, independent of pre-processing. However, unlike the other tools presented, JMRUI
has a large user dependence. Preprocessing, ltering, and frequency and phase calibrations
are all handled by the user. Additionally, the basis set simulations are subject to user dened
processing such as apodization, which can further aect tting. While we acknowledge that
an experienced user could enhance the performance of the tool, perhaps even beyond that
of its competitors, the very fact that there is a user dependence is an issue in quantication,
where results need to be reproducible across multiple scanners, patients, and acquisitions.
The variability of results across all basis set tools illustrate the shortcomings of this method.
Any deviation of the spectrum from its ideal line shape leads to misidentication of the
concentrations. In-vivo, this eect is often masked by the sheer size of the basis sets. One of
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Tarquin's brain basis sets, for instance, contains thirty four individual models. Misidenti-
cation of one metabolite is often masked, as its signal is attributed to one of the other nearby
model. The only non-basis set tool considered, GANNET, performs to a similar standard
as the basis set methods. For GABA1, GANNET is found to estimate a large negative
gradient, however, excluding two of the points brings the gradient from -27.8761103 with
CI (-89.2030,33.4506)103, to 0.3396 (0.2730, 0.4062). This value is in line with other tools,
but the extremity of the outliers requires further investigation. When outliers are excluded,
GANNET achieves a good R2 for the solution series, however, it too underestimates the
concentration. A surprising result is that simple in-house peak tting method appears the
most consistent across the series. R2 is above 0.95 for all solution series, and 0.79 for the
gel series. While still underestimating the true concentration ratios, the estimates are more
consistent, and closer to the expected ratios than for any of the more sophisticated tools
covered. This is a surprising result in itself. While perhaps not a viable option for standard
spectroscopy sequences, simple tting methods such as these can potentially be applied to
specialist techniques such as MEGA-PRESS, and appear to provide a robust means of quan-
tication. In this study, the manual analysis provides a good baseline for the experiment,
and exhibits the presence of spectral information, even where more advanced methods are
unable to detect it. This suggest the potential for over-processing of data, to the point where
information is lost.
Closer inspection of the spectra suggest that spectra 2 and 3 in the room temperature
GLX series suer from poor B0 homogeneity and poor water suppression, respectively. If
these data points are excluded from the t of the room temperature gel series, then the
estimated concentration ratio increases to 30% of its actual value with R2 of 0.95. it also
appears that the body temperature gels perform generally better, a surprising result, given
the expected broadening of the peaks.
5.6 Conclusion
While basis set methods have proven more popular, the results of this study indicate a
potential weakness of this analysis. Misidentication appears common, and in practice could
be concealed by the presence of nearby models, leaving the user unaware of the issue. This
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eect is compounded for lower quality spectra, where the potential for misidentication
increases. GANNET performs to a similar standard as the basis methods, across the solution
series, but its performance drops considerably for the gel data. The relatively basic peak
integration approach taken here, appears to be the most robust of the methods examined.
This is surprising, and suggests over processing of the data, by other methods. While
not feasible for standard in-vivo spectroscopy, these simple methods could have their place
in analysis of specialist sequences such as MEGA-PRESS, and new techniques that can
simplify the spectral landscape. This may be the analysis of choice for the techniques in the
subsequent chapter.
This study could be easily extended to include more basis sets and quantication targets,
and is considered a possible avenue of future work. Furthermore, a follow-up study using
in-vivo data would allow more clinically relevant conclusions to be drawn. In general, our
ndings suggest a need for consistency. As with the relaxometry protocols, care must be
taken when comparing more than one acquisition or analysis method, and standardisation
is needed where possible.
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6 Novel techniques for quantication of metabolites by
MRS
6.1 Introduction
Traditional RF pulses are tailored to produce a rotation, typically 90, or 180, to excite and
refocus the magnetisation. MEGA-PRESS is one exception, using frequency selective pulses
to edit the spectrum, however there are limitations to this technique. MEGA-PRESS uses
the coupling of two resonances to generate signal in the dierence spectrum, and is therefore
limited in its potential application. It also requires twice as many acquisitions as a standard
spectroscopy sequence, to produce a reduced peak amplitude in the dierence spectrum.
Quantum optimal control is a general optimisation technique used to develop a set of
control elds that can optimally manipulate a quantum system towards an established goal.
The goal itself will vary by application, whether its achieving a state with minimised energy
or time expenditure, or, more critically for us, moving a set of systems from an initial
state, to some specied nal state [144]. The general process involves quantum mechanical
simulation of a system under the inuence of a control eld, then iterative renement of that
eld until the system achieves its target state. The precise nature of the renement procedure
is dened by the quantum control algorithm, of which there are many variations. Control
optimisation may be attempted in both the frequency domain [145] and time domain, for
continuous or piece-wise constant controls. Controls formulated in the time domain, in a
piecewise manner, are the focus here, where there are two main approaches; Krotov-type
methods [146, 147] which update all controls within a single time slice before proceeding
on to the next time slice, and GRAPE-type methods [148] which update all controls in all
time slices concurrently [149]. Quantum optimal control is a relatively general technique and
has been applied in many areas including the design of quantum gates [150, 151], trapped
ions [152{154], and other spectroscopic applications [155{157].
Quantum control has also been applied to magnetic resonance, where the Bloch equations
model the signal, and RF pulses are optimised as the control medium. Band selective pulses
have been derived [158{160], as well as robust 90 and 180 pulses [161{163]. We propose a
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method of developing chemically selective RF pulses for magnetic resonance spectroscopy.
A magnetic resonance spectroscopy Hamiltonian, and full Liouville space, simulation
package was implemented in Swansea, then incorporated into a quantum control framework
by Max Chandler and Frank Langbein at Cardi University. The structure of a given
metabolite is modelled as a network of nuclear spins, characterised by their chemical shifts,
and J-coupling to other spins within the network. The chemical shift and J-coupling may be
quantied from spectra, usually derived from high resolution NMR. The models used in this
study are cited, with sources, in Appendix. C. Simulations are restricted to systems with 7
spins or fewer, due to the exponential increase in computational cost as the system grows.
There are methods capable of simulating large molecules, using approximations [164], but
molecular structure is key to its controllability. The target state of a particular metabolite
may be any (reachable) quantum state, but we want to dene one that produces favourable
spectroscopic features, i.e. the peaks of the target metabolite enhanced, while the peaks
of interfering metabolites are simultaneously suppressed. We also need optimal pulses to
account for a range of experimental instabilities. Variation in the local B0 strength, will
displace the chemical shifts, rendering unstable RF pulses ineective. B1 homogeneity will
also vary, both spatially and temporally, deforming the eective pulse amplitude. Errors are
estimated, and incorporated into target function, ensuring optimal pulses are robust with
respect to these inhomogeneities. The theoretical basis for the simulation will be discussed
rst.
6.2 Quantum mechanical simulation of MR pulse sequences
6.2.1 Hamiltonian models
The simulations were formulated using a Hamiltonian model, where metabolites are repre-
sented as networks of nuclear spins, parametrised by their chemical shift and J-coupling.
The Hamiltonian used was of the following form:
1
h
H0 = nn
(n)
z + mnJmn
 
(m)x  (n)x + (m)y  (n)y + (m)z  (n)z

; (6.1)
where  is the chemical shift, Jmn is the coupling between the m and n
th spin, and z is the
z Pauli matrix. The total Hamiltonian, H, is the sum of this system Hamiltonian, and the
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Hamiltonians dening external controls. The dynamics of the full system are described by
the Schrodinger equation (6.2):
ih
@
@t
j	i = H j	i ; (6.2)
where h is Planck's reduced constant, 	 is the wavefunction. We may then write the wave-
function in terms of a unitary propagator, U :
j	(t)i = U(t; t0) j	(t0)i ; (6.3)
U(t; t0) = e
 i
h
H(t t0); (6.4)
where t0 is the initial time, and t is some later time. In MRS we do not deal with individual
spin systems, we observe the cumulative eect of the contribution of many spin systems.
In the following, we assume the t0 = 0. This ensemble of spins is formulated in terms of a
density matrix, :
 = j	(t)i h	(t)j = U(t) j	0i h	0jU y(t); (6.5)
with the following equation of motion:
_(t) =   i
h
[H; (t)] : (6.6)
Observations on this system are made by measuring the transverse magnetisation, perpen-
dicular to the main eld. In our framework this corresponds to the observables, Fx and
Fy:
F nx = I 
 x 
 I; (6.7)
F ny = I 
 y 
 I; (6.8)
where the N-fold tensor product consists of N-1 identity matrices, with  as the nth factor.
x and y are the Pauli x, and y matrices respectively. In practice we measure the collective
magnetisation of all spins, e.g. the sum over all F nx . Measurements performed upon these
observables are achieved by taking the following traces:
hMxi = tr (Fx) ; (6.9)
hMyi = tr (Fy) ; (6.10)
where  is the density matrix describing the system prior to measurement.
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6.2.2 RF elds
Initially, the systems must be prepared in some state. This may be the ground state of the
system, the lowest energy state, or some thermal state. A thermal state, 0, for specic
temperature, T , may be specied using Boltzmann statistics:
0 = e
 hH0=KbT ; (6.11)
where H0 is the system Hamiltonian, and Kb is the Boltzmann constant. With an initial
state specied, the next step is the simulation of the pulse sequence itself. The simulated
sequences consist of pulses | either ideal rotations, or piece wise simulation of pulse shapes
| and periods of free evolution, followed by observation. The simplest way to simulate an
RF pulse is to reduce it to an ideal rotation in the x or y directions, respectively, represented
by a unitary propagator:
U = e iFx ; (6.12)
U = e iFy ; (6.13)
where  is the angle of rotation. This method instantaneously rotates the ensemble by the
specied angle, however, it ignores the time-based evolution eects of the system. More
faithful recreation of an RF pulse requires simulation of each time step from the piece-wise
pulse. This achieved by generating a unitary operator for each time step in the pulse:
U = e 2iHtott; (6.14)
where Htot is the total Hamiltonian; including the system Hamiltonian plus the control
Hamiltonian. In between pulses, the system is allowed to evolve for some time,  , governed
by the system Hamiltonian. This period of free evolution can be described by a single unitary
operator:
U = e 2iH0 : (6.15)
After encoding all the pulses and evolution periods, we then need to make a measurement
upon the system. In a real MRS experiment, measurement entails Npts repeated signal
acquisitions, over a specied dwell time, TD. The acquired signal is therefore Npts  TD in
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length. This is approximated by taking repeated observations of the operator, Fm:
Fm = Fx + iFy; (6.16)
i.e.
hMmi = tr (Fm) ; (6.17)
and then evolving the system by the dwell time using Eq. (6.15). This process is then
repeated Npts times to construct the FID signal, which may then be Fourier transformed to
acquire a spectrum for the system described by the Hamiltonian. FID, PRESS, STEAM,
and LASER sequences were implemented in this fashion, as well as an array of common
metabolic spin systems (Appendix. C).
6.2.3 Dissipative simulation
If the current Hilbert space simulation is allowed to propagate for some large time, the ob-
served signal in Mm will continue to oscillate, but never decay. In practice this is not what
we see, a real system undergoes decoherence, and will relax back to its equilibrium mag-
netisation. This eect can be simulated by including dissipation. To properly simulate this
dissipation, the dynamics must be reformulated in Liouville space. We dene the Liouvillian:
L =  i[H0] + n

R1D


(n)
 

+R2D
 
(n)z

; (6.18)
where R1 and R2 are the inverse of T1, and T2 respectively.   is the lowering operator.We
dene the super-operator, D, acting on some operator, v:
D(v) = vvy   1
2
 
vyv+ vyv

: (6.19)
resulting spectra are broader, and lower in amplitude do de-phasing, more in line with ex-
perimental data than the sharp resolved peaks. This method also allows the relaxation
dynamics with a pulse to be captured. However, this extra accuracy comes at a cost. For
Hamiltonian simulations, the size of the density matrix for an N spin system scales with 2N .
For a Liouville system, the matrix size scales with
 
2N
2
. For larger spin systems, such as
NAA, a single sequence simulation can be on the order of several hours. For this reason, it
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was deemed infeasible to use dissipative simulations during the optimisation process. Dis-
sipation is included during the robustness analysis of pulses, so as to reduce the number of
calculations, while still examining the eects.
6.3 Optimisation using optimal control
6.3.1 Theory of optimal control
The evolution of the controlled system is governed by a total Hamiltonian, H, which is
dependent upon the system Hamiltonian, H0 (Eq. (6.1)), and some other RF dependent
component. The RF pulse is modelled as a time-varying control eld, f(t), where f is a
classical eld. H may be represented as a linear perturbation of H0 by a set of control
Hamiltonians, Hm. The control Hamiltonians are formulated as an expansion of the x
and y Pauli matrices, representing coils in the x and y dimension, respectively. The total
Hamiltonian is the sum of these controls and the system Hamiltonian:
H(t) = H0 +
MX
m=1
fm(t)Hm: (6.20)
For algorithmic purposes, time will be discretised, either implicitly, or explicitly. The M
time-independent control Hamiltonians, have a corresponding time-dependent control vector,
fm, where fm has a discrete amplitude for each time step. Here we have formulated the
problem in terms of discrete time steps. There are many ways to approach this problem, we
examined two such approaches. State transfer problems seek to nd a eld, f , that transfers
the system from its initial state, (0), to some specically dened target state, tar, by some
time, T . The success of the control is dened by a transfer delity, F :
F(f) = tr(tar(T )): (6.21)
Transfer delity is maximised when the Hilbert-Schmidt distance is minimised. An error
functional, E, may be dened, accordingly:
E(f) =
1
2
jj(T )  tarjj2S ; (6.22)
= E0  F(f); (6.23)
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where E0 is a constant with value tr(
2
0) + tr(
2
tar). This is perhaps less intuitive, as the
target is dened as a specic quantum state, rather than a physical observable. However it
is also possible to optimise in this way. Observable optimisation problems search for controls
that deliver a certain expectation value from an observable operator, Q. The transfer delity
in this case is given by:
F(f) = tr(Q(T )): (6.24)
A similar form to Eq. (6.21), but distinct in the formulation of the target. Full details may
be found in calculations by Shermer et al. [165]. In the simulation of pulse sequences, the
quantum mechanical propagator can become very time consuming to compute. In situations
such as these, local gradients are often calculated to reduce the number of computationally
expensive function calls [166]. In our case optimisation is performed using a box-constrained,
limited-memory variant of the BFGS algorithm, L-BFGS-B [167]. The controls are then
updated concurrently to reduce the impact of propagator calculations on computational
load. The gradients themselves may be calculated analytically. The exact analytic gradients
for state transfer problems has been studied extensively in other arenas, and so the solutions
are readily available. Machnes et al. [149] found the derivative for the gradient to be:
@f(U(tk))
@uj
=
1
c
Re
 
tr

ytar(tk)

@Uk
@uj

0(tk   1)U yk

+ tr
(
ytar(tk)Uk0(tk   1)
 
@U yk
@uj
!)!
;
(6.25)
with @Uk
@uj
as follows :

l
 @U@uj m

=
8><>: it hljHj jmi e
 itl if l = m
 it hljHj jmi e itl e itm it(l m) if l 6= m
(6.26)
 are the Eigenvectors of the Hamiltonian, U are the unitary propagators, and j and k
are indices. The specications of the optimal pulses are also limited to the capabilities
of our scanner. RF amplitudes, pulse duration and resolution are all constrained within
specications of our 3 Tesla Siemens Magnetrom, where the maximum pulse amplitude is
capped at 800 rad s 1, and minimum scanner transmit time is set to 25 ns.
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6.3.2 Target state selection, objective functions, and constraints
The optimal choice of target state for a chemically selective RF pulse is not immediately
obvious. Initial attempts at identifying GABA selective pulses involved simply optimising for
maximal observed GABA signal, while suppressing that of the other peaks. As per Eq. (6.24),
the spectrum was acquired, and the integral of the total signal prole used as a gure of
merit. While in principle this seems sensible, algorithmically it is an ill dened target,
with the algorithm unable to converge to a high delity. As such, in the second instance,
optimisation was reformulated as a state transfer problem. There are many potential choices
of target state that can provide favourable results. We attempted to optimise an excitation
of a subset of spins within a molecule. It is possible to construct states where individual
constituent spins of a system lie in dierent quantum states. For example, for a three spin
system we can generate a state where only the rst spin is excited:
j	i = 1p
2
(j"i+ j#i)
 j#i 
 j#i : (6.27)
Fig. 6.1 shows several simulated GABA spectra (using the model by Govidaraju et al. ),
whereby the spin system was initialised with one of its six spins in an excited state, while
the other ve remain in the ground state. The spectrum in each case is a modulated singlet,
with the other resonances producing little to no signal over the readout duration. Initial
optimisation targets were selected by manually selecting spins within a molecule to excite
and suppress. In one case we attempted to generate a control to simultaneously excite a
sub group of spins in the creatine and GABA models. For the GABA spin system, only the
resonances at 2.28 PPM were to be excited, and only the 3.91 PPM resonance of creatine.
While perhaps not an ideal in-vivo pulse, it would eliminate any overlap in the signal of
the two metabolites. The current target states are automatically identied, chosen as a
combination of excited protons that maximise the separation of resulting resonances. If
multiple protons of a given system are within  0.05 PPM of the chosen peak, they are also
are added as an excitation target.
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Figure 6.1: Simulated GABA spectrum. Single spins are excited and an FID immediately
acquired.
6.3.3 Robustness considerations
Within the discussion so far, pulses may be identied that allow theoretical discrimination
of previously indistinguishable spectra. While the simulated control may achieve a high
delity state transfer, experimental implementation brings with it many additional inuences
that are not present in the basic Hamiltonian simulation. The most critical factors are
the inhomogeneities of the B0 and B1 elds. The Hamiltonian simulation assumes no o-
resonance eects, and any deviation from this may destroy the selectivity of some pulses.
Inhomogeneity in the B0 eld will shift spins from a single resonance frequency, to a
Gaussian distribution of Larmor frequencies. In the spectra this is tantamount to the chem-
ical shifts becoming distributed about some mean, and manifests itself as peak broadening.
This is integrated into the optimisation process by repeated simulation of the system with
an additional Hamiltonian component, adding a z resonance oset. The range and resolu-
tion of B0 to be investigated will inevitably increase the computational cost of simulation,
so must be balanced with eciency. Each set of metabolites is simulated up to 10 Hz o
resonance, at 1 Hz intervals. RF pulses are tested across this full range, and are required to
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maintain state transfer delity at each point.
B1 inhomogeneity is a more complex issue. Where B0 instabilities aect the distribution
of chemical shifts, B1 eects manipulate the pulse itself in both spatial distribution, modu-
lating the eective ip angle, and temporal prole, distorting the features of the pulse. B1
variation is implemented with three facets, eective ip angle, noise, and RF amplication
error. While the term ip angle is perhaps less applicable to a chemically selective pulse,
the underlying principle of pulse energy is. The optimised pulse is assumed to possess an
eective 90 ip angle, and is simulated with  5, in 1 intervals, scaling the pulse energy.
Noise is incorporated as a normally distributed, random perturbation of each time step. The
degree of perturbation is scaled as a percentage of the amplitude, varied from 1% to 10%,
in 1% increments. The resulting spectra are averaged over ten repeat runs before analysis.
Optimised RF pulses can have complex, rapid varying pulse proles. While the scanner
limitations are accounted for in optimisation, we may still observe distortion of the pulse
during amplication. RF amplier error is approximated by a Savitzky-Golay, polynomial
lter applied to the pulse. The lter smooths the RF pulse prole, aecting high frequency
variations more. The pulse is ltered with varying bucket size (1, 5, 7, 9, 11, 13), and the
delity examined in each case.
Finally, the performance of the pulse is assessed under full dissipative simulation. While
it is too computationally expensive to model dissipation during the optimisation process,
it will still have an eect, in particular T2 dissipation. T1 and T2 times of the models are
estimated from literature values [168{170], then varied between 80% and 120% of this value,
in 5% increments. in each case, the state transfer delity is assessed.
6.3.4 Localisation
The current optimisations are performed for a simple FID sequence, where the system is
prepared in the ground state, the control pulse applied, followed immediately by readout.
While this is deemed sucient for initial experimental implementations, the neglect of any
localisation scheme renders such pulses less eective in-vivo. Furthermore, including the
current optimised pulses into a standard localisation scheme like PRESS or STEAM will
destroy selectivity during refocussing and long evolution times. It may be possible to include
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some form of conventional localisation scheme into the optimisation process, whereby the
simulation is expanded to an entire sequence, and refocussing pulses designed to maintain
selectivity. However, this will come at a signicant computational cost, and will further
reduce the search space of the algorithm, perhaps making it unrealistic, at least in the rst
instance.
One potential solution we propose is outer volume suppression, to be used in conjunction
with the FID sequence we have optimised for. Outer volume suppression utilises slice selective
RF pulses to excite all spins outside the selected voxel. This is closely followed by a set of
strong crusher gradients to de-phase the signal, in a similar vein to CHESS water suppression.
Outer volume suppression is most commonly used to augment other localisation schemes
[171], to reduce the eects of spurious signals originating outside the target voxel. However,
more recent work has vindicated the use of outer volume suppression as a localisation scheme
in its own right [172{174].
6.4 Optimisation results
6.4.1 Theoretical evaluation of optimised pulses
The optimisation framework has generated hundreds of pulses for various targets, and with
varying success. The full analysis of these results is beyond the scope of my own thesis,
so only selected examples are discussed here. Fig. 6.2, and Fig. 6.3 show the pulse proles
of two successful optimisation results. \GABA 106", and \GABA 147" were optimised to
discriminate between GABA and creatine. GABA 106 aims to suppress the 3.0 PPM peak
creatine, and concurrently maximise the signal of the 2.3 PPM resonance of GABA, while
suppressing the others. The GABA 147 pulse also suppresses creatine, but this time exciting
the 1.8 PPM resonance of GABA. While these choices may well not be the optimal for in-
vivo data acquisitions, they are adequate for illustrative purposes, and proof of principle.
Both pulses appear surprisingly simple in their real and imaginary proles, exhibiting high
frequency modulations embedded into lower frequency line shapes. However more complex
features are observed in the phase of both pulses, with several large switches from positive to
negative phase. To visualise the eects of these pulses, their action upon GABA and creatine
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(a) Real and imaginary (b) Magnitude and phase
Figure 6.2: Optimised pulse: \GABA 106".
(a) Real and imaginary (b) Maginitude and phase
Figure 6.3: Optimised pulse: \GABA 147".
is simulated. Fig. 6.4 shows the simulation results for creatine under inuence of each pulses,
as well as the ideal FID, for comparison. GABA 106 produces a 99% reduction in the 3 PPM
creatine resonance, and a 90% reduction in the 3.9 PPM resonance, compared to that of the
FID. Similarly, the GABA 147 pulses produces a 96% reduction of creatine at 3 PPM, and
95% at 3.9 PPM. Both pulses are able to successfully suppress the creatine signal at 3 PPM
to 5% it's original value. These results were generated using the Govindaraju model for
GABA. To investigate the eects of model choice, the optimal pulses were simulated for all
three GABA models considered here; Govindaraju, Kaiser, and Near. Fig. 6.5 shows the
results for the Govindaraju model. Optimised pulse GABA 106 reduces the magnitude of
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(a) Ideal (b) GABA 106 (c) GABA 147
Figure 6.4: Spectra for ideal sequence, and two optimised pulses for creatine.
(a) Ideal (b) GABA 106 (c) GABA 147
Figure 6.5: Spectra for ideal sequence, and two optimised pulses for Govindaraju GABA
model.
the 3 PPM GABA resonance by 94%, a similar delity to that of the creatine. The target
2.3 PPM resonance of GABA is also reduced by the pulse, but only by around 28%. The
resulting spectrum is eectively a single resonance at 2.3 PPM, and this single component
is reected in the relatively simple FID. Imperfect excitation, and J-coupling eects during
readout, mean some degree of signal loss is almost inevitable. For pulse GABA 147, the
2.3 PPM peak is reduced by 72%, the 3PPM peak by 91%, and the 1.8 PPM resonance by
only 16%. In the case of the Kaiser model, GABA 106 reduces the 2.3 PPM peak by 62%,
while the 3 PPM peak is suppressed by 98%. For GABA 147, the 2.3 and 3 PPM peaks
are reduced by 86%, and 96%, respectively. GABA 147 reduces the 1.8 PPM resonance by
78% for the Kaiser model. Finally, for the Near model, GABA 106 reduces the 2.3 and 3
PPM peaks by 61% and 97%, respectively. While the GABA 147 reduces them by 85%, and
93%, respectively. The 1.8 PPM resonance is reduced by 65%. As expected, the choice of
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(a) Ideal (b) GABA 106 (c) GABA 147
Figure 6.6: Spectra for ideal sequence, and two optimised pulses for Kaiser GABA model.
(a) Ideal (b) GABA 106 (c) GABA 147
Figure 6.7: Spectra for ideal sequence, and two optimised pulses for Near GABA model.
GABA model does indeed aect the delity of the RF pulse. While selectivity may still be
seen to varying extent, the pulses make use of the minor dierences in coupling structure to
drive selectivity. This selectivity is inevitably lost when said structure changes. This again
highlights the need for accurate metabolite models.
While a frequency selective pulse from a MEGA sequence will only aect resonances
within its edit bandwidth, these optimised pulses will aect all spins, and the resulting spec-
trum is non-trivial. The results presented here were aimed at discriminating Cr and GABA,
but in order to quantify these results, other overlapping resonances must be considered.
Fig. 6.8 shows the aect of these pulses on glutamate, glutamine, and NAA. Generally the
optimised pulses appear to reduce the magnitude of all resonances to varying degrees. The
complex structure of the optimised pulse does generate excitations outside of the intended
target, but the excitation is not optimal, so the resonances are drastically reduced in mag-
nitude. In principle this is positive, however the same process will occur in the intended
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(a) Glu - Ideal (b) Glu - GABA 106 (c) Glu - GABA 147
(d) Gln - Ideal (e) Gln - GABA 106 (f) Gln - GABA 147
(g) NAA - Ideal (h) NAA 106 (i) NAA 147
Figure 6.8: Spectra of optimised pulses for glutamate, glutamine, and NAA.
targets if the models used in optimisation are not accurate.
6.4.2 Experimental evaluation of optimised pulses
Optimised pulses were implemented into basic FID spectroscopy sequence using the Siemens
IDEA pulse programming environment by Sophie Shermer. The optimised RF pulses were
uploaded to the scanner's pulse library, and the standard FID sequence modied to utilise
them. The water suppression scheme was unchanged, and localisation can, in principle, be
achieved using outer volume suppression. Optimised pulses have amplitudes specied in units
of Rabi frequency or rad s 1. These units must be converted to transmit voltages, requiring
102
calibration of the transmitter to determine the correct settings. This is complicated by the
fact that these voltage settings depend on the dielectric and RF absorption properties of the
phantom, its placement relative to the transmitter, and the characteristics of the hardware
itself. Transmitter calibration is a common technique, however, conventional transmitter
calibration | based on stimulated to spin echo ratios | is not possible here. A simplistic
calibration we can perform is to x the pulse shape, duration, and all other parameters, and
systematically vary transmitter voltage.
For a non-selective excitation pulse, we expect some variation in peak amplitudes, espe-
cially for very low voltages, but the relative heights of a peak should remain stable for a given
metabolite. This is exactly what we observe in Fig. 6.9(a), for a standard FID sequence,
with a 400 µs broadband RF excitation pulse. The broadband pulse excites all transitions
and the three characteristic clusters of GABA peaks are visible in all spectra, except at
extremely low voltages, where the peaks are obscured due to very low SNR. The stability of
the spectrum with respect to transmitter voltage is desirable, it demonstrates the robustness
of the pulse with respect to B1 inhomogeneity.
(a) Standard FID (b) Chemically selective pulse
Figure 6.9: Comparison of reference voltage calibration spectra for a standard FID, and an
FID with a chemically selective pulse
Repeating this experiment, with the non-selective pulses replaced with the new optimised
pulses produces very dierent results. For low transmitter voltages, the spectra produce no
peaks, aside from some baseline. As the voltage is increased, some peaks begin to emerge,
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and the spectral prole of GABA is changed as the voltage is increased further. In particu-
lar, around 450 V, a distinct two-peak pattern emerges, with the 3 PPM GABA resonance
beginning to be suppressed. Unfortunately, at this point, the transmitter prevented further
increases in the voltage due to the hardware constraints of our scanner.
The maximum transmitter voltage is limited to 1.2 times the reference voltage; the voltage
required to achieve a  rotation of the water signal, using a 1 ms non-selective, rectangular
pulse. This is determined automatically by the scanner after phantom placement, using the
previously mentioned calibration sequence. While it is possible to overwrite the reference
voltage, doing so results in failure of all other pulses whose amplitudes are linked to this ref-
erence voltage, and therefore loss of water and outer volume suppression. This, too, could be
circumvented by a sequence that performs a full manual calibration of the transmitter for all
pulses, including water suppression. Implementation of this will be explored in future work.
The results highlight the importance of hardware limitations, and the need to characterize
these experimentally.
6.4.3 Experimental B1 mapping and calibration
Even after the voltage has been calibrated, there will inevitably still be local B1 eld inho-
mogeneity. This results on dierent eective RF amplitudes across the extent of the sample.
As we have seen, the conventional FID sequence is extremely robust with regard to such
inhomogeneities, but optimal pulses will still be aected. To assess the degree of spatial
inhomogeneity, B1 eld mapping can be performed. B1 mapping was applied to a GABA
phantom, and an oil phantom with two imaging planes. The sequence consists of a square ex-
citation pulse of varying ip angle, , with frequency and phase encoding about a slice select
refocussing pulse, as shown in Fig. 6.10. Fig. 6.11 shows a series of B1 maps acquired for a
variety of transmitter voltages. The contrast of the image lies in the distribution of eective
ip angles in the sample, a feature which varies with transmitter voltage. Careful shimming
and transmitter calibration can improve B1 homogeneity, but it will always be a limiting
factor in data quality, especially at high eld strengths, where the eect is compounded.
In the case of optimal pulses, selectivity will be destroyed by broad B1 distributions, and
previously suppressed signals will begin to emerge.
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Figure 6.10: B1 mapping sequence diagram.
Through localisation, it is possible restrict the excited volume, and therefore reduce the
eects of B1 spatial inhomogeneity in the nal signal. However, the optimal RF pulses rely
on complex amplitude and phase modulations, and the ability of the transmitter to accu-
rately reproduce them. For conventional pulses, this process is not normally required, where
the performance of the pulse can essentially be dened by the voltage calibration. There is,
however a Siemens service sequence able to directly measure the waveforms produced by the
transmitter, using the built-in RF receive coils. Fig. 6.13, and Fig. 6.12 show the temporal
pulse proles for a set of sinc, and rectangular pulses, respectively. The proles allow visu-
alisation of the transmitted pulses, over their duration, and multiple acquisitions. This was
done for a variety of pulse lengths, and some interesting eects are observed. Short pulses
appear unable to return to the zero baseline signal, creating a residual tail in the proles.
This is observed for both sinc and rectangular pulses. There is also a signicant discrepancy
between the two receive channels. While channel two is able to produce reasonable results
for the longer pulses, the rst channel consistently produces a dip in the centre. This kind
of imperfect B1 prole is an issue that needs to be addressed for the optimised RF pulses to
work.
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(a) Oil phantom - Transverse (b) Oil phantom - Sagital (c) GABA phantom
Figure 6.11: B1 eld maps for an oil, and GABA phantom. Contrast reects dierences in
ip angles resulting from B1 inhomogeneity.
(a) (b)
(c) (d)
Figure 6.12: Rectangular pulse
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(a) (b)
(c) (d)
Figure 6.13: Sinc pulse
6.5 Conclusion
Pulses have been identied by the optimisation framework that allow discrimination of previ-
ously indiscernible spectroscopic signals. Simulations demonstrate a robustness of the pulses
with respect to B0 and B1 inhomogeneities, and relaxation. The success of these pulses is
dependent upon the accuracy of the underlying models. As seen in the previous chapter,
there is variation in the reported chemical shifts and J-couplings. While these dierences
appear supercial in quantication, they are of greater importance in the optimisation, as
the small model dierences are the basis of manipulation. The validity of the models needs to
be assessed, and the errors quantied. Model uncertainty could then be included into the op-
timisation process, enhancing the performance of pulses. Localisation remains problematic.
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Standard schemes destroying chemical selectivity, so signal localisation must be incorporated
into the simulation, at signicant computational cost, or outer volume suppression must be
used.
Investigation into the calibration of the RF pulses has presented several pertinent ques-
tions. Can the scanner software produce the correct pulse shape? Is this shape damaged
during amplication? Is the transmission delity high enough? Assessing each stage of this
pipeline is important to ascertain the origin of any experimental errors. As future work, we
plan to investigate this using an oscilloscope to measure the pre-amplied RF output of the
scanner, and a Gauss probe to measure the actual eld being created in the bore. Char-
acterisation of any experimental issues here will need to be addressed before any work can
continue. Conversely, if both of these stages produce reasonable results, then the model and
simulation can be considered as the primary source of error, and the focus of further study.
Successful experimental implication of chemically selective pulses would be a signicant re-
sult. It could provide an alternative to spectral editing and two-dimensional techniques for
in-vivo spectroscopy. The generality of the technique will allow application to many other
target states and metabolites, and renement of the process towards in-vivo use.
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7 Conclusion
The results presented in this thesis clearly show that MRI/S has considerable potential as
a quantitative imaging technique, and as a tool for quantication of biomarkers. However,
the pulse sequences, protocols, and analysis methods investigated in this thesis appear in-
adequate to access the full extent of available information. The initial study conducted into
the calibration of MRI test objects served as a solid foundation for much of the subsequent
experimental work. The well characterised, stable phantoms were a reliable baseline, and
allowed the establishment of a ground truth with which to compare results. Calibrated re-
laxometry and spectroscopy studies are not possible in-vivo, the work conducted here would
not have been nearly as informative without the ground truth phantom results. Our results
suggest agarose as the most stable gelling agent, with R2 of 0.96, and 0.99 for r1 and r2
ts, respectively. While the agar results aren't as convincing, it is suggested as a cheaper
alternative to agarose.
The comparative analysis of R1 mapping techniques using both in-vivo data, and well
characterized phantoms shows that there is considerable variability in the estimated R1.
In-vivo R1 measurements show a considerable methodological dependence, with SR and IR
t-test p-values ranging from 0 - 10 10. While the relaxivity t quality, and temporal stability
of r1 estimates for a given sequence further vindicate the phantom preparation procedures,
the variation of such a fundamental MR parameter by acquisition mode is a troubling nding
for quantitative imaging. If the purported gold standard inversion recovery sequence is taken
as a ground truth, other methods consistently over estimate longitudinal relaxivity. In the
case of the variable ip angle methods, r1 appears to be overestimated by around 60%. This
is an important nding for contrast enhanced MRI, where these fast R1 mapping methods
are used to quantify contrast agent uptake. Our results suggest a methodological dependence
of relaxivity quantication methods, so comparing these fast mapping methods to inversion
recovery maps, for instance, may not be best practice. DCE R1 maps should ideally be
compared to one acquired using the same sequence, to avoid introducing a systematic error.
While the inconsistency of the various acquisition methods in the R1 study is a concerning
result, it does provide an interesting avenue of further study. The results appear to conrm
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inversion recovery as the gold standard technique, but the erroneous component of the other
methods could still be present, even in these results. This, indeed, begs the question, what
are we measuring? Further work is needed to fully investigate these issues, and until then,
comparison of the measured T1 should be restricted to specic acquisition methods to avoid
any methodological dependencies.
Further complications are noted for spectroscopic techniques. Although in principle, the
detection of biomarkers from unique spectroscopic signature should be easy, in practice it
is far from straightforward, and there are many issues. Quantication is hampered by the
temperature dependent water shift, potential pH eects to spectra, peak broadening due to
many underlying causes, phase errors, and also varying contributions from lipids and macro-
molecules in-vivo. Moreover, as seen in this thesis, the concentration ratios reported by
dierent analysis tools can vary greatly. With the exception of Tarquin, all tools appear to
underestimate the actual GABA to NAA ratio. Solution series gradient linearity is generally
good, with R2 rarely dropping below 0.85 across all analysis tools. However, this is not the
case for the gel series, where R2 is consistently lower, and with a broader distribution of val-
ues. This exhibits the drop in performance as a result of imperfect data. The broader peaks
of the gel data are far more challenging to t, especially for a xed basis set. Conversely, a
consistent nding is the relatively good performance of the basic peak integration methods in
both gradient estimation, and linearity. The robustness of these simple methods is promis-
ing, and could be seen as an alternative approach for specialist techniques, for example the
optimised RF spectra. These results illustrate the need for studies on phantoms with known
composition to establish a ground truth. In-vivo data is often analysed in multiple tools,
with the discrepancies explained in relation to t error. As stated previously, these errors
can often obscure the real picture, with misidentied signals being attributed to other basis
sets. The phantom work conducted here was able to establish a ground truth with which
to compare to, allowing further appraisal of the quantication tools. Furthermore, this data
set could be used to benchmark new analysis methods against the existing tools, allowing a
quantitative measure of the success of quantication.
The chemically selective RF pulses presented here may address some of these problems,
but will also present new challenges of their own. Model accuracy, eld homogeneity, es-
110
pecially over large volumes and/or high eld strengths, and perhaps most fundamentally,
the limitations of the RF transmitter. Initial optimisation results have identied pulses able
to enforce single resonance excitation for multiple models simultaneously. Despite stringent
requirements with regard to the pulse's characteristics, and experimental robustness, RF-
pulses have been identied that are able to discriminate between molecules as similar as
Glutamate and glutamine. This is not commonly possible at 3T, so is an exciting prospec-
tive result. Attempts experimentally verify the pulses have highlighted the need for careful
calibration, especially with regard to transmitter voltage.
The models of metabolites are fundamental in the nal two chapters of this thesis, form-
ing the basis of MRS analysis software, and the dynamics of the simulator. While the eect
of basis appears to be small in the analysis, the relative simplicity of the GABA and NAA
MEGA-PRESS spectra is perhaps not the sternest test. Complete analysis of conventional
PRESS or STEAM spectra will require more accurate quantication of the molecular struc-
tures underlying the basis sets. For the RF optimisation work, these parameters are far more
fundamental. When trying to nd pulses that can discriminate between similar molecules,
for example glutamine and glutamate, the minor dierences become the sources of selectivity,
so the model accuracy is paramount. However, our simulated results suggest that current
pulses exhibit a relatively high robustness with respect to model variation, which bodes well
for future work. Quantication of the models could even be an avenue of future work. High
concentration metabolite phantoms could be made, and scanned over a range of sequence
timings to elucidate the couplings and chemical shifts. These results could be utilised in both
the analysis and optimisation work. One encouraging nding of the MRS quantication work
is the relatively high quality of the peak integration methods. The commonly used MRS
software would not be applicable to optimised spectra, without the generation of a specic
basis set. The better option may be the simple analysis, at least in the context of phantom
experiments.
Overall, there is certainly potential for quantitative imaging methods to thrive within
MRI. Current techniques in relaxometry and spectroscopy, while promising, lack the nu-
merical robustness required to become purely quantitative techniques. Generally, there is a
need for standardisation. Both MRS and relaxometry have a method-dependent component
111
to their analyses, but show reasonable consistency for intra-method comparisons. Further
work is required to address these inconsistencies, but in the mean time, standardisation of
protocols and analysis is recommended. Only then could these methods become truly quan-
titative. Additionally, while the experimental implementation of chemically selective pulses
may be some way o, the potential applications for them are both numerous, and exciting.
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A Supplementary material for test object analysis
Gelling agent Concentration R1 (s
 1) R2 R2 (s 1) R2
Agar
1.0% 0.362 (0.342 , 0.383) 0.9996 6.282 (6.357 , 6.208) 0.9991
1.5% 0.389 (0.365 , 0.414) 0.9994 5.008 (5.098 , 4.918) 0.9980
2.0% 0.395 (0.373 , 0.417) 0.9995 11.275 (11.657 , 10.892) 0.9956
2.5% 0.409 (0.387 , 0.432) 0.9995 8.604 (8.892 , 8.315) 0.9960
3.0% 0.414 (0.398 , 0.431) 0.9997 9.956 (10.383 , 9.529) 0.9940
3.5% 0.469 (0.456 , 0.482) 0.9999 12.675 (13.059 , 12.290) 0.9953
Agarose
0.5% 0.348 (0.330 , 0.367) 0.9996 4.911 (4.950 , 4.872) 0.9996
1.0% 0.351 (0.332 , 0.370) 0.9996 8.534 (8.689 , 8.379) 0.9982
1.5% 0.367 (0.345 , 0.390) 0.9995 12.037 (12.512 , 11.562) 0.9933
2.0% 0.385 (0.353 , 0.418) 0.9989 15.609 (16.655 , 14.564) 0.9820
2.5% 0.391 (0.363 , 0.419) 0.9992 18.495 (20.310 , 16.680) 0.9715
3.0% 0.399 (0.375 , 0.422) 0.9995 21.261 (24.158 , 18.363) 0.9639
PVA
10% 0.690 (0.686 , 0.694) 1.0000 6.141 (6.183 , 6.099) 0.9997
15% 0.892 (0.883 , 0.901) 1.0000 11.130 (11.329 , 10.932) 0.9983
20% 1.069 (1.058 , 1.081) 1.0000 13.417 (13.826 , 13.009) 0.9965
Table A.1: R1 and R2 values obtained from tting, with 95% condence interval, and R
2
t error.
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Gelling agent R2 - 2016 R2 - 2017
Agar
1.0% 6.282 (6.357 , 6.208) 6.25 (6.15 , 6.35)
1.5% 5.008 (5.098 , 4.918) 7.46 (7.35 , 7.58)
2.0% 11.275 (11.657 , 10.892) 11.54 (11.24 , 11.85)
2.5% 8.604 (8.892 , 8.315) 8.34 (8.15 8.53)
3.0% 9.956 (10.383 , 9.529) 10.36 (10.09 , 10.64)
3.5% 12.675 (13.059 , 12.290) 12.89 (12.50 , 13.29)
Agarose
0.5% 4.911 (4.950 , 4.872) 4.98 (4.89 , 5.16)
1.0% 8.534 (8.689 , 8.379) 8.76 (8.61 , 8.92)
1.5% 12.037 (12.512 , 11.562) 12.33 (11.97 , 12.68)
2.0% 15.609 (16.655 , 14.564) 15.82 (15.01 , 16.62)
2.5% 18.495 (20.310 , 16.680) 19.81 (18.14 , 21.48)
3.0% 21.261 (24.158 , 18.363) 22.14 (19.90 , 24.39)
Table A.2: R2 quantication resulting from two scan session over six months apart.
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Contrast agent Concentration R1 (s
 1) R2
Gd2O3 Sept 16
0.002759mM 1.070 (1.012 , 1.127) 0.9990
0.005517mM 1.533 (1.414 , 1.651) 0.9978
0.013793mM 2.622 (2.406 , 2.838) 0.9971
0.027586mM 9.084 (8.973 , 9.195) 0.9998
0.055173mM 11.382 (11.284 , 11.481) 0.9999
0.082759mM 13.249 (12.702 , 13.796) 0.9963
0.110346mM 20.410 (19.589 , 21.231) 0.9931
0.137932mM 30.825 (29.194 , 32.456) 0.9769
Gd2O3 Jan 18
0.002759mM 1.038 (0.976 , 1.100) 0.9989
0.005517mM 1.285 (1.205 , 1.365) 0.9987
0.013793mM 2.545 (2.369 , 2.720) 0.9980
0.027586mM 8.411 (8.232 , 8.591) 0.9994
0.055173mM 11.240 (11.156 , 11.324) 0.9999
0.082759mM 13.139 (12.551 , 13.728) 0.9957
0.110346mM 19.259 (18.381 , 20.137) 0.9921
0.137932mM 30.791 (28.835 , 32.747) 0.9672
Gd2O3 Jan 18
0.002759mM 0.763 (0.723 , 0.802) 0.9994
0.005517mM 1.249 (1.159 , 1.339) 0.9983
0.013793mM 2.425 (2.211 , 2.638) 0.9968
0.027586mM 7.825 (7.612 , 8.038) 0.9992
0.055173mM 9.483 (8.940 , 10.026) 0.9955
0.082759mM 13.294 (12.767 , 13.820) 0.9966
0.110346mM 21.466 (21.093 , 21.839) 0.9986
Table A.3: R1 ts for Gd2O3 scans, with 95% convidence intervals, and R
2 values
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Contrast agent Concentration R1 (s
 1) R2
MnCl2 July 16
0.000000mM 0.331 (0.304 , 0.358) 1.0000
0.050528mM 0.853 (0.815 , 0.891) 0.9999
0.101056mM 1.341 (1.270 , 1.413) 0.9998
0.151584mM 1.935 (1.910 , 1.960) 1.0000
0.202112mM 2.920 (2.878 , 2.962) 1.0000
0.252640mM 3.055 (2.981 , 3.130) 0.9999
0.303168mM 4.221 (4.154 , 4.288) 0.9999
MnCl2 Nov 17
0.000000mM 0.363 (0.329 , 0.396) 0.9997
0.050528mM 1.045 (0.992 , 1.098) 0.9997
0.101056mM 1.249 (1.085 , 1.413) 0.9977
0.151584mM 1.680 (1.511 , 1.849) 0.9984
0.202112mM 2.626 (2.546 , 2.705) 0.9998
0.252640mM 2.967 (2.717 , 3.217) 0.9982
0.303168mM 4.112 (3.795 , 4.429) 0.9980
MnCl2 Nov 17
0.000000mM 0.375 (0.358 , 0.393) 0.9998
0.050528mM 1.012 (0.983 , 1.041) 0.9998
0.101056mM 1.280 (1.172 , 1.387) 0.9982
0.151584mM 1.691 (1.561 , 1.821) 0.9982
0.202112mM 2.567 (2.541 , 2.593) 1.0000
0.252640mM 3.003 (2.809 , 3.198) 0.9980
0.303168mM 4.178 (3.948 , 4.408) 0.9980
Table A.4: R1 ts for MnCl2 scans, with 95% convidence intervals, and R
2 values
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Contrast agent Concentration R2 (s
 1) R2
Gd2O3
0.002759mM 10.136 (10.245 , 10.027) 0.9973
0.005517mM 10.830 (10.941 , 10.719) 0.9977
0.013793mM 13.115 (13.255 , 12.975) 0.9978
0.027586mM 19.161 (19.389 , 18.933) 0.9985
0.055173mM 22.810 (23.157 , 22.462) 0.9983
0.082759mM 27.850 (28.317 , 27.382) 0.9981
0.110346mM 35.802 (36.669 , 34.935) 0.9970
0.137932mM 47.156 (48.430 , 45.881) 0.9968
MnCl2 July 16
0.000000mM 7.061 (7.139 , 6.982) 0.9992
0.050528mM 12.986 (13.464 , 12.508) 0.9928
0.101056mM 19.230 (20.789 , 17.672) 0.9772
0.151584mM 22.070 (22.988 , 21.151) 0.9952
0.202112mM 26.439 (27.844 , 25.034) 0.9922
0.252640mM 31.720 (33.915 , 29.524) 0.9904
0.303168mM 40.536 (45.184 , 35.888) 0.9838
MnCl2 Nov 17
0.000000mM 7.817 (7.937 , 7.696) 0.9983
0.050528mM 14.213 (14.946 , 13.480) 0.9852
0.101056mM 18.931 (20.211 , 17.651) 0.9817
0.151584mM 24.727 (27.440 , 22.014) 0.9705
0.202112mM 31.349 (37.881 , 24.818) 0.9387
0.252640mM 41.710 (56.628 , 26.792) 0.8864
0.303168mM 52.987 (82.688 , 23.286) 0.8079
MnCl2 Nov 17
0.000000mM 7.791 (7.909 , 7.672) 0.9983
0.050528mM 14.395 (15.258 , 13.533) 0.9784
0.101056mM 18.993 (20.313 , 17.674) 0.9807
0.151584mM 25.862 (29.514 , 22.209) 0.9428
0.202112mM 31.562 (38.451 , 24.674) 0.9331
0.252640mM 41.453 (54.457 , 28.450) 0.8711
0.303168mM 57.390 (100.832 , 13.947) 0.7708
Table A.5: R2 ts for both Gd2O3 and MnCl2 scans, with 95% convidence intervals, and
R2 values.
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B Supplementary material for relaxometry
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Figure B.1: VFA series images with R1 maps obtained using only two ip angles (2 and 15
degrees) and 9 ip angles (2; 3; 4; 6; 8; 10; 12; 13; 15 degrees) for MnCl2 gels.
120
(a) IR Series (b) SR Series
Figure B.2: Inversion recovery and saturation recovery images for MnCl2 solutions.
(a) IR Graphs (b) SR Graphs
Figure B.3: Mean signal vs TI (TR) graphs for MnCl2 contrast solutions. The error bars
indicate the variation of the signal over the ROI. The solid lines are the curves of best t.
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(a) IR Series (b) SR Series
Figure B.4: Inversion recovery and saturation recovery images for MnCl2 gel phantoms.
(a) IR Graphs (b) SR Graphs
Figure B.5: Mean signal vs TI (TR) graphs for MnCl2 contrast gel phantoms. The error
bars indicate the variation of the signal over the ROI. The solid lines are the curves of best
t.
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(a) 2-point methods with dierent TR (b) 9-point(red) and 12-point(green) relaxivity
curves for MnCl2 gels
Figure B.6: Relaxivity of MnCl2 gel phantoms for dierent VFA methods
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C Tables of chemical shifts and coupling constants for
various metabolites.
V (PPM) J1 (Hz) J2 (Hz) J3 (Hz) J4 (Hz) J5 (Hz) J6 (Hz)
6.649 0 0 0 0 0 0
3.027 0 0 0 0 0 0
3.027 0 0 0 0 0 0
3.027 0 0 0 0 0 0
3.913 0 0 0 0 0 0
3.913 0 0 0 0 0 0
Table C.1: Chemical shifts and scalar couplings of Creatine [1]. Notice the zero-valued
coupling matrix. Creatine is a set of 3 uncoupled resonances.
V (PPM) J1 (Hz) J2 (Hz) J3 (Hz) J4 (Hz) J5 (Hz) J6 (Hz)
3.0128 0 0 5.372 7.127 0 0
3.0128 0 0 10.578 6.982 0 0
1.889 5.372 10.578 0 0 7.755 7.432
1.889 7.127 6.982 0 0 6.173 7.933
2.284 0 0 7.755 6.173 0 0
2.284 0 0 7.432 7.933 0 0
Table C.2: Chemical shifts and scalar couplings of Govindarau GABA model [1]
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V (PPM) J1 (Hz) J2 (Hz) J3 (Hz) J4 (Hz) J5 (Hz) J6 (Hz)
2.284 0 0 7.352 7.352 0 0
2.284 0 0 7.352 7.352 0 0
1.888 7.352 7.352 0 0 6.377 7.96
1.888 7.352 7.352 0 0 8.138 7.495
3.012 0 0 6.377 8.138 0 0
3.012 0 0 7.96 7.495 0 0
Table C.3: Chemical shifts and scalar couplings of Kaiser GABA model [2]
V (PPM) J1 (Hz) J2 (Hz) J3 (Hz) J4 (Hz) J5 (Hz) J6 (Hz)
2.284 0 -15.938 7.678 6.98 0 0
2.284 -15.938 0 6.98 7.678 0 0
1.888 7.678 6.98 0 -15 8.51 6.503
1.888 6.98 7.678 -15 0 6.503 8.51
3.013 0 0 8.51 6.503 0 -14.062
3.013 0 0 6.503 8.51 -14.062 0
Table C.4: Chemical shifts and scalar couplings of Near GABA model [3]
V (PPM) J1 (Hz) J2 (Hz) J3 (Hz) J4 (Hz) J5 (Hz)
3.7433 0 7.331 4.651 0 0
2.0375 7.331 0 -14.848 6.413 8.406
2.12 4.651 -14.848 0 8.478 6.875
2.3378 0 6.413 8.478 0 -15.915
2.352 0 8.406 6.875 -15.915 0
Table C.5: Chemical shifts and scalar couplings of Glutamate [1].
125
V (PPM) J1 (Hz) J2 (Hz) J3 (Hz) J4 (Hz) J5 (Hz)
3.753 0 5.847 6.5 0 0
2.129 5.847 0 -14.504 9.165 6.347
2.109 6.5 -14.504 0 6.324 9.209
2.432 0 9.165 6.324 0 -15.371
2.454 0 6.347 9.209 -15.371 0
Table C.6: Chemical shifts and scalar couplings of Glutamine [1].
V (PPM) J1 (Hz) J2 (Hz)
3.548 0 0
3.548 0 0
Table C.7: Chemical shifts and scalar couplings of Glycine [1].
V (PPM) J1 (Hz) J2 (Hz) J3 (Hz) J4 (Hz)
4.0974 0 6.933 6.933 6.933
1.3142 6.933 0 0 0
1.3142 6.933 0 0 0
1.3142 6.933 0 0 0
Table C.8: Chemical shifts and scalar couplings of Lactate [1]
V (PPM) J1 (Hz) J2 (Hz) J3 (Hz) J4 (Hz) J5 (Hz) J6 (Hz)
3.5217 0 2.889 0 0 0 9.998
4.0538 2.889 0 3.006 0 0 0
3.5217 0 3.006 0 9.997 0 0
3.6144 0 0 9.997 0 9.485 0
3.269 0 0 0 9.485 0 9.482
3.6144 9.998 0 0 0 9.482 0
Table C.9: Chemical shifts and scalar couplings of myo-inositol [1].
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V (PPM) J1 (Hz) J2 (Hz) J3 (Hz) J4 (Hz) J5 (Hz) J6 (Hz) J7 (Hz)
4.3817 0 3.861 3.861 6.4 0 0 0
2.6727 3.861 0 -15.592 0 3.861 3.861 3.861
2.4863 3.861 -15.592 0 0 3.861 3.861 3.861
7.8205 6.4 0 0 0 6.4 6.4 6.4
2.008 0 3.861 3.861 6.4 0 0 0
2.008 0 3.861 3.861 6.4 0 0 0
2.008 0 3.861 3.861 6.4 0 0 0
Table C.10: Chemical shifts and scalar couplings of NAA [1].
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D FID-A simulated results.
(a) 1.0mmol (b) 2.0mmol (c) 3.0mmol
(d) 4.0mmol (e) 5.0mmol (f) 6.0mmol
Figure D.1
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(a) 7.0mmol (b) 8.0mmol (c) 9.0mmol
(d) 10.0mmol (e) 11.0mmol (f) 12.0mmol
Figure D.1: FID-A simulated series with Near et al. GABA model, 15 mmol NAA, 8 mmol
creatine.
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(g) 1.0mmol (h) 2.0mmol (i) 3.0mmol
(j) 4.0mmol (k) 5.0mmol (l) 6.0mmol
Figure D.2
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(a) 7.0mmol (b) 8.0mmol (c) 9.0mmol
(d) 10.0mmol (e) 11.0mmol (f) 12.0mmol
Figure D.2: FID-A simulated series with Govindaraju et al. GABA model, 15 mmol NAA,
8 mmol creatine.
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(g) 1.0mmol (h) 2.0mmol (i) 3.0mmol
(j) 4.0mmol (k) 5.0mmol (l) 6.0mmol
Figure D.3
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(a) 7.0mmol (b) 8.0mmol (c) 9.0mmol
(d) 11.0mmol (e) 12.0mmol
Figure D.3: FID-A simulated series with Near et al. GABA model, 15 mmol NAA, 8 mmol
creatine, 12 mmol glutamate, 3 mmol glutamine.
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(f) 1.0mmol (g) 2.0mmol (h) 3.0mmol
(i) 4.0mmol (j) 5.0mmol (k) 6.0mmol
Figure D.4
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(a) 7.0mmol (b) 8.0mmol (c) 9.0mmol
(d) 11.0mmol (e) 12.0mmol
Figure D.4: FID-A simulated series with Govindaraju et al. GABA model, 15 mmol NAA,
8 mmol creatine, 12 mmol glutamate, 3 mmol glutamine.
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(f) 1.0mmol (g) 2.0mmol (h) 3.0mmol
(i) 4.0mmol (j) 5.0mmol (k) 6.0mmol
Figure D.5
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(a) 7.0mmol (b) 8.0mmol (c) 9.0mmol
(d) 10.0mmol (e) 11.0mmol (f) 12.0mmol
Figure D.5: FID-A simulated series with Kaiser et al. GABA model, 15 mmol NAA,
8 mmol creatine, 12 mmol glutamate, 3 mmol glutamine.
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